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ABSTRACT 
 
Rotavirus-associated diarrhea is a common enteric disease in piglets. Group A, B, and C 
rotaviruses have been implicated in US swine. While group A rotaviruses have been widely 
studied and attributed as a major cause of the disease, little known about group B and C 
rotaviruses with respect to their pathogenicity/pathogenesis as well as diagnostics and 
prevention/control. To address such shortfalls, three studies were carried out. 
The objective of the first study was producing monoclonal antibodies (MAbs) against 
PoRV A, B, and C. To that goal, full-length VP6 protein gene of each serogroup was cloned 
from feces positive for respective virus and expressed in a baculovirus system using Bac-to-Bac 
cloning and expression kits. The recombinant proteins, purified in their native conditions, were 
used to immunize mice. A VP6-based ELISA and an indirect fluorescent antibody test using Sf9 
cells expressing VP6 of PoRV A, B or C were used to screen hybridomas. The protein specificity 
of selected MAbs were further verified by Western immunoblot, and the isotype of each MAb 
was determined using a commercial murine antibody isotyping kit. Based on all these 
evaluations, MAb 10A11, 10B1 and 11H3, which were of IgG isotype, were selected for PoRV 
A, B and C, respectively. The MAbs specific for PoRV A and C were proven to be useful for 
immunohistochemical staining to detect these viruses in formalin-fixed intestinal tissues, which 
can aid more accurate diagnostic investigation of rotavirus-associated diarrhea. 
The second study was to compare the pathogenicity of porcine rotavirus (PoRV) A, B 
and C individually or in combinations in immunologically naïve newborn piglets. Forty-eight 
one-day-old Cesarean-Derived Colostrum-Deprived (CDCD) pigs were divided into eight groups. 
Pigs in each group were challenged with rotaviruses that belong to individual group A, B, C or 
all combinations. Clinical signs including diarrhea were recorded every 12 hpi. Rectal swabs 
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were obtained before inoculation and then every 12 hpi. Half of the pigs in each group were 
euthanized at 24 hours post inoculation (hpi) and the rest at 72 hpi. Intestinal contents were 
collected at necropsy. The swabs and contents were tested by RT-PCR for virus shedding. 
Multiple parts of the intestine (duodenum, proximal jejunum, mid jejunum, distal jejunum, and 
ileum) were collected for histopathology. There was no remarkable difference in the occurrence 
and appearance of diarrhea caused by PoRV A, B, and C or combinations. The onset of PoRV B 
and C fecal shedding was earlier than that of PoRV A. All viruses were able to cause atrophic 
enteritis. Although the lesions caused by PoRV A were more prevalent in mid to distal jejunum, 
the antigen was found throughout of small intestine. In contrast, PoRV B and C caused atrophic 
enteritis through the entire small intestine with detection of corresponding viral nucleic acid or 
antigen, respectively. This study showed that all rotavirus groups were equally pathogenic to 
immunologically naïve neonates but may vary in their replication patterns in intestine. 
The third study was conducted to establish an in vitro method to isolate and propagate 
non-group A rotaviruses since a suitable virus isolation method was not available. Two IPEC cell 
lines (IPEC-1 and IPEC-J2), which are epithelial cells originated from small intestines of neonate 
pigs, were adopted to virus isolation test. Virus isolations were attempted on fecal samples 
collected from neonatal piglets experimentally inoculated with PoRV B or C. By applying a 
roller culture technique with a high concentration of trypsin in maintenance media, a PoRV C 
strain designated IA/2015 (G6P[5]I5) was successfully isolated and sustained at a high titer in 
IPEC-1 cells, but not IPEC-2, while PRV B could not be isolated. The isolate and newly 
established virus isolation method can be useful for further studies of PoRV C, diagnostic assay 
development as well as for vaccine production. 
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CHAPTER1. GENERAL INTRODUCTION 
Dissertation organization 
 
My dissertation contains an abstract, a literature review, three research chapters, a general 
conclusion and an acknowledgement. Chapter 1, literature review, presents the overviews of 
porcine rotavirus in term of classification, epidemiology, immunity, pathogenicity, clinical signs, 
diagnosis, and prevention. Chapter 2, 3, and 4, are research papers which have been prepared for 
publication. Chapter 5 provides the general conclusions of the studies. 
 
GENERAL OVERVIEW OF PORCINE ROTAVIRUS AND ITS INFECTION IN SWINE 
 
I. The virus 
1.1 Taxonomy and classification 
 Porcine rotavirus (PoRV) belongs to the genus Rotavirus in the family Reoviridae. 
Rotaviruses (RVs) are divided into ten groups (A-J) base on the antigenicity or the sequence of 
VP6, one of the capsid proteins (1, 2, 3, 4). Of these groups, groups A, B, C, E, and H have been 
reported to cause disease in pigs (5, 6). In each group, rotaviruses are further classified into P and 
G serotypes and genotypes based on VP4 (protease sensitive protein) and VP7 (glycoprotein), 
respectively, which are outer capsid proteins (7). For serogroup A rotaviruses, serotypes are 
designated by neutralization assays in which viruses having less than “20-fold difference 
between homologous and heterologous reciprocal neutralizing antibody titers” are grouped into 
the same serotype (8). On the other hand, genotypes are designated by comparing virus 
sequences. In the case of rotavirus A (RVA), viruses sharing ≥80% nucleotide identity of VP4 
are considered to be in the same P genotype while 80% nucleotide identity of VP7 is also used as 
cut-off for G typing (9). Because VP4 and VP7 stimulate neutralizing antibody response and the 
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homotypic immune response is important in protection, it is imperative to identify G and P type 
of each rotavirus strain. Serotypes are indicated by the number right after G or P (e.g., G1P1) 
whereas genotype is expressed by the number in the square bracket after G or P (e.g., G1P[1]). 
The G genotypes and serotypes are coherent and interrelated. Due to lack of P-type specific 
monoclonal antibodies, the relation between P genotypes and serotypes have not been well 
determined. Geographic distribution and prevalence of G and P types of porcine rotavirus A 
(PoRV A) is shown in Table 1. For the more precise classification of RVs in case of reassortants, 
a classification system which uses nucleotide sequence comparisons and phylogenetic analyses 
of all 11 viral genomic RNA segments has been suggested for group A rotaviruses (9, 10). The 
notation Gx-P[x]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx is used for the VP7-VP4-VP6-VP1-VP2-
VP3-NSP1-NSP2-NSP3-NSP4-NSP5/6 genes, respectively, which is further explained in Table 
2. Such a systemic classification using the entire 11 genome segments is not available for non-
group A rotaviruses. 
For porcine rotavirus B (PoRV B), limited sequence information is available. Only NSP2 
(11, 12), NSP5 (12), and VP7 (12-14), and VP6 (15) have been characterized. The identified G 
types to date are summarized in Table 3. Although there is no consensual cut-off for G 
genotyping of group B porcine rotaviruses,  ≥76% and 79% identity for nucleotide and amino 
acid sequence respectively (13) or ≥80% nucleotide identity (15) have been used as cut-off. For 
porcine rotavirus C (PoRV C), there have been a growing number of reports of virus molecular 
characterization since 2013. The G and P types identified for PoRV C to date are summarized in 
Table 4. For G types, the cut-off for grouping is ≥85% identity of nucleotide sequence for VP7 
(16, 17). For P typing, ≥80% (18) or ≥83% (19) nucleotide identity of VP4 sequence has been 
used. It appeared that G6 P[5] has been the dominant genotype among PoRV C in Japan (18) and 
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Brazil  (20), while the dominant P and G genotype combination of PoRV C in US swine is not 
known. 
1.2 Genome and morphology 
The rotavirus genome has 11 segments of double-stranded RNA which encode six 
structure proteins (VP1,2,3,4,6,7) and six nonstructural proteins (NSP1,2,3,4,5,6) (7), shown in 
Table 5. Migration patterns of rotavirus RNA segments on a gel known as RNA 
electropherotypes, which can be visualized by polyacrylamide electrophoresis (PAGE), are 
unique for each of rotavirus groups A, B, C, and D (21). There is no information about 
electropherotype of rotavirus group E and H which have also been detected in pigs. Because 
eclectropherotypes have not been adequate for the identification of groups or types (21), PCR-
based assays or sequencing have become a common tool for grouping or typing.  As such, 
PAGE-based electrophenotyping is no longer very useful in characterizing rotaviruses. 
Regardless of groups, rotaviruses have the same morphology (22), that is a wheel-shape, 
non-enveloped icosahedral virion (Figure 1). The size of rotaviruses is comparable between 
group A, B, and C, ranging from 65 nm to 80 nm in diameter. The mature virion has three layers 
of the capsid making a double-shelled capsid (Figure 2). The most inner layer consists of 120 
VP2 units which are organized in a T=1 symmetry and is constituted by 12 decamers. A decamer 
is built by five VP2 dimers (i.e., VP2A and VP2B) around a five-fold symmetry axis. The core 
layer acts as a cage for the viral RNA-dependent RNA polymerase (VP1), the 
guanylyltransferase  and methylase (VP3) and the viral genome (23). The middle layer consists 
of 260 trimers of VP6 for group A (24), whereas that of group C contains 240 trimers of VP6 
(25). There is no such information regarding VP6 of group B, D and E. VP6 has the biggest mass 
among the rotaviral proteins and helps to stabilize the capsid by interacting with VP7 on the top 
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and VP2 on the bottom. The stabilized capsid is important for virus entry as well as virus 
replication inside the infected cell. VP6 forms double-layered particles with VP2 which serve as 
a place for the initial viral gene transcription (See details under 1.3). The most outer layer 
comprises of 60 spikes of trimeric VP4 and 260 trimers of VP7(26), which are crucial for virus 
attachment and entry into target cells. There are 132 channels connecting the core with the outer 
layer, which is a distinctive feature of rotavirus virion. 
1.3 Replication in cells 
The replication of rotavirus is not fully understood. The entry of rotavirus to the cells is a 
multistep process, which requires VP7 and the proteolytic cleavage of VP4 into VP5 and VP8. 
The VP8 first binds to cell receptors such as histo-blood group antigen (27) or gangliosides 
containing sialic acid (28). VP5 and VP7 then interact with several co-receptors such as integrin 
(α2β1, ανβ3, αхβ2, α4β1) and/or heat shock cognate protein (hsc70). All the receptors may be 
localized in a close proximity of lipid rafts which serve as a platform for the interaction between 
rotavirus and cellular receptors (29).  
The internalization of rotavirus has been controversial. Different rotavirus strains may 
have different entry pathways. The rotavirus is known to enter cells through receptor-mediated 
endocytosis (30). The OSU strain of PoRV A was shown to enter MA-104 cells, African green 
monkey kidney cell line, by receptor-mediated endocytosis (30). The coordination of VP4 and 
VP7 in receptor binding helps the virus disrupt the endosomal membrane to be released to the 
cytoplasm. In this process, due to low intracellular calcium concentration, the outer layer of the 
virus is removed to form double-layered particles (DLP) of VP6 and VP2. Besides receptor-
mediated endocytosis, it has also been demonstrated that the virus may enter cells by direct 
penetration because some lysosomotropic agents (ammonium chloride, chloquine, methylamine, 
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amantadine and dansylcadaverine) and endocytosis inhibitor (sodium azide and dinitrophenol), 
which have been known to interfere with receptor-mediated endocytosis pathway of viruses, 
could not prevent virus entry to the cells (31, 32).  
Rotaviruses are known to carry their own replicating complexes which bind to the inner 
side of VP2. The replicating complexes contain VP1 (RNA-dependent RNA polymerase) and 
VP3 (guanylyltransferase and methylase). The viral positive-sense single-stranded RNAs, which 
are capped and non-polyadenylated, are transcribed in DLP then released into cytoplasm through 
chanels. The transcribed RNAs are then used for either viral protein production (i.e., translation) 
or virus genome replication.  
Interactions of NSP2 and NSP5 result in the formation of cytoplasmic inclusion bodies 
named viroplasm that attracts VP1, VP2, VP3, and VP6. In the viroplasm, the assembly of these 
structure proteins forms DLPs. The initial assembly complexes are formed by the binding of VP2 
and VP1/VP3. Positive-sense RNAs are then incorporated into these complexes with the help of 
NSP2 for negative-sense RNA synthesis and formation of double-stranded RNAs. The virion 
cores are formed as a result of the assembly of 12 initial assembly complexes, which are covered 
by VP6 to form new DLPs. Then, DLPs move to endoplasmic reticulum to get outer layer (VP4 
and VP7) with help of NSP4. NSP4, which binds to VP7 to make NSP4-VP7 complexes in 
endoplasmic reticulum membrane, have an affinity to VP6(33). Virions were released from the 
infected cells by smooth vesicles through the apical side of intestinal cells (34) and cell lysis (35, 
36).  
 1.4 Physicochemical properties  
Some of the physical and chemical properties of rotavirus have been studied by others. 
Due to the characteristic triple layered structure without envelope, rotavirus is resilient to 
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solvents (ether, chloroform), refrigerants (e.g., Genetron®), detergents, repeated freeze-thawing, 
and sonication (37). All group A, B, and C rotaviruses are, however, sensitive to a high 
temperature, but their thermostability varies among strains. In one study, the infectivity of a 
simian rotavirus A (SA11 strain) in MA-104 cells was decreased by 80% and 99% after placing 
at 50°C for 5 and 30 minutes, respectively, as determined by plaque assay (37). In another study 
(38), the strain SA11 and FH4232 (human rotavirus A) were sensitive to a higher temperature 
(4°C for 22 days, 37°C for 7 hours to 14 days, 56°C for 15 minutes, 80°C and 100°C for 1 
minute). Although the infectivity of Gottfried strain (PoRV A) was reported to be stable at 56°C 
for 30 minutes (39). Murine rotavirus B in the intestinal filtrate which was treated at 56°C for 30 
minutes could not cause diarrhea in suckling rats (40). The infectivity of PoRV C (Cowden strain) 
in MA-104 cells was reduced to 1% when incubated at 56°C for 30 minutes (39).  
The pH stability of rotavirus A has been studied by numerous investigators. According to 
Estes, et al (37), the infectivity of the SA11 strain was reduced to 70% and 60% of the original 
titer when placing for 1 hour at pH 3.5 and 10, respectively. However, Meng (38) stated that the 
infectivity of the SA11 and FH4232 strains was not changed when they were treated in pH 3 to 
11 at 37°C for 1 hour. This difference appears to be due to the methods used to measure virus 
infectivity as immunofluorescence test which was used in the latter study is more sensitive than 
plaque assay which was used in the former study. Nevertheless, Terrett (39) showed that the 
OSU strain lost 27% and 0% of the original titer when treated at pH 3 and pH 5for 30 minutes at 
37°C, respectively, while Gottfried strain lost 17% and 11% of the original titer, respectively, 
under the identical conditions. Overall, these data suggest that RVA is relatively stable in a wide 
range of pH although strain variation is apparent. Murine rotavirus B in intestinal filtrates could 
not cause diarrhea in suckling rat after being treated at pH 3 for 30 minutes at 37°C (40). Porcine 
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rotavirus C (Cowden strain) lost 16% and 17% of its original titer when treated at pH 3 and pH 5 
for 30 minutes at 37°C, respectively while NB strain lost 34% and 0%, respectively, under the 
same condition (39).  
The density of rotavirus A, B, and C are similar, ranging from 1.36 to 1.38 g/ml. 
Rotaviruses can be seen in the form of single-layered, double-layered or triple-layered particles, 
which can be separated by a rate-zonal centrifugation method using cesium chloride or sucrose 
gradient due to the difference in density. For RVA, double-layered particles are sedimented at 
380S to 400S on a sucrose gradient cushion and have a density of 1.38 g/ml in CsCl gradient 
whereas triple-layered particles are sedimented at 520S to 530S on the sucrose gradient cushion 
and have a density of 1.36 g/ml in CsCl gradient (7). Group B human rotavirus (HRV) has the 
density of 1.373 g/ml and 1.435 g/ml for double- and single-layered particles, respectively(41). 
PoRV C has the density of 1.369 g/ml and 1.387 g/ml for double- and single-layered particles, 
respectively (22). 
II. Pathogenesis 
The understanding of rotavirus pathogenesis is primarily based on studies of RVA. After 
being ingested, rotavirus targets mature, non-dividing enterocytes of villi (generally tip of the 
villus) in the small intestine, leading to diarrhea. Malabsorption is widely accepted as a cause for 
diarrhea (21). The outcome of virus replication in intestinal epithelial cells is cell lysis leading to 
villous blunting and atrophy. Such changes result in a large amount of undigested and 
unabsorbed particles in the lumen of small intestine, which are osmotically active and eventually 
travel to the colon. When the colon cannot absorb or hold water any longer, diarrhea due to 
osmosis starts. In addition, affected pigs that developed diarrhea have shown some defective 
functional changes in small intestinal epithelial cells, such as decreasing in the activity of 
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digestive enzymes (e.g., sucrase, lactase, maltase) and Na+K+ATPase which is crucial to 
transport nutrients into cells and increasing the activity of thymidine kinase (42). All these 
changes occur due to damage in small intestinal epithelia and contribute to malabsorption.  
It has been reported that diarrhea can be developed before the presence of pathological 
changes in the small intestine (43, 44), suggesting that other factors or mechanisms may also 
contribute to diarrhea. One of them is production of NSP4 which is considered as an enterotoxin 
of rotavirus. During rotaviral replication, expressed NSP4 causes an increase of intracellular 
calcium concentration ([Ca2+]i) (45, 46). When it is released from infected cells, NSP4 can act as 
paracrine to adjacent uninfected cells by stimulating a phospholipase C-inositol 1,3,5- 
triphosphate (PLC-IP3) cascade, resulting in a surge of [Ca2+]i. The high [Ca2+]i depresses the 
expression of disaccharidases, leading to suboptimal digestion of disaccharides in the intestine,  
which eventually contributes to malabsorption. High [Ca2+]i also disrupts the microvillar 
cytoskeleton network and the tight junctions which leads to increased paracellular permeability 
and activates Cl- transporter, causing increasing secretion of cryptic cells. NSP4 or serotonin 
secreted from enterochromatin cells are thought to stimulate enteric nervous system which 
attributes to increasing intestinal secretion and mobility (47). These events contribute to the 
development of diarrhea.                    
The severity of disease in pigs varies depending on age, immune status, and insulting 
rotavirus strain and serogroup. There is conflicting information on age resistance of pigs to 
rotavirus A. One study (48) reported that the rotavirus-associated disease was most common in 
1- to 4-week-old piglets in which diarrhea was severe and villous atrophy was prominent while 
diarrhea in 1- to 3-day-old pigs was mild. The authors postulated that such a difference may have 
been attributed to the difference in the level of materially derived immunity between the 2 
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groups. The authors speculated that the maternal antibody in the older pigs had been decreased to 
a lower level than the neonatal pigs at the time of exposure to rotavirus. In contrast, another 
study of experimental rotavirus infection in 3 week-old pigs (49) showed that the pigs had mild 
diarrhea and lesions in small intestine. Furthermore, another investigators could not prove the 
age resistance of pigs to rotavirus as the infectivity scores measured by immunoperoxidase 
testing on  intestine segments of neonatal pigs and 2- to 12-week-old pigs were not significantly 
different (50). Reasons for the observed discrepancy may have been differences in the immune 
status of pigs used and/or viral strain used. Nonetheless, older pigs are generally believed to 
manage rotavirus infection and disease better than neonatal pigs because: a) the older pigs have 
fewer receptors on the surface of enterocyte (51); b) the enterocyte turnover rate in the older pigs 
is 2-3 times quicker than that in neonatal pigs (52) and; c) the ability of the colon to absorb water 
is higher in older pigs than neonates. 
While the small intestine is the main replication site of rotaviruses, RVA antigen and 
RNA were detected in non-intestinal tissues of infected pigs, such as mesenteric lymph nodes, 
liver, lung, and choroid plexus (53). Especially, a high amount of the viral antigen and RNA was 
detected in mesenteric lymph nodes with microscopic lesions such as necrosis and depletion of 
lymphoid cells, suggesting that rotavirus could replicate in mesenteric lymph nodes. However, 
such a speculation cannot be confirmed because virus isolation attempts were not reported. In the 
other positive tissues, the amount of antigen was low and the amount of RNA was similar to that 
in blood, indicating that rotavirus may be passively transported to these tissues due to viremia. 
Viremia was detectable at 1 day post inoculation (dpi) and last until 14 dpi. Transient viremia 
from 1 to 7 dpi in inoculated pigs has also been reported by other investigators (54). These 
investigators proposed hypothetical mechanisms by which rotavirus enters the blood stream. One, 
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the virus may use antigen-presenting cells as transporters. Two, the virus may pass through cell 
barriers because NSP4 may increase the blood flow through villi, leading leakage or transport the 
virus into blood circulation. Three, the virus may go through the basement membrane when the 
intestinal epithelial cells are detached. Nonetheless, the clinical and biological importance of 
rotaviral viremia and non-intestinal replication are largely unknown. 
Strain difference in the pathogenicity has been observed. Two group A porcine rotavirus 
strains designated OSU and SDSU had shown similar clinical signs, changes in body weight gain, 
and virus excretion patterns in experimentally infected pigs (55). The microscopic lesions in the 
small intestine induced by the 2 strains were also similar although villous atrophy and villous 
fusion caused by the SDSU strain at 3 and 7 dpi were more severe than those by the OSU strain. 
It is unknown though whether these two strains are similar at the molecular level because the 
sequence of SDSU strain is not available. In other report (56), two PoRV A isolates (4F and 4S) 
were obtained from the same diarrheic pig but showed different in-vitro growing characteristics 
in MA-104 cells. The isolate 4F grew more slowly and created smaller plaques than the isolate 
4S. Molecularly, the isolate 4F had gene 4 (VP4) that migrated faster than that of the isolate 4S 
in electrophoresis. When gnotobiotic pigs were inoculated with these isolates for continuous pig 
passages ranging from 1 to 5, the isolate 4F caused diarrhea but not the isolate 4S. Sequence 
comparison revealed that the two isolate shared 99.2 % and 99.8% amino acid identity for VP6 
and NSP1(NS53) respectively, but shared 67.3% and 70.6% nucleotide and amino acid identity, 
respectively, for VP4 (57). Such a strain difference in the pathogenicity has also been 
demonstrated with a bovine rotavirus (58).  
Several rotavirus proteins are considered as viral virulence factors. VP4, VP3, VP7, 
NSP1, NSP2, and NSP4 have been reported to contribute to the virus pathogenicity (59). Among 
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these viral proteins, NSP4 as enterotoxin is strongly believed to be a virulent factor because it 
has been reported to play a role in causing diarrhea particularly in a murine model. It appears that 
NSP4 can cause diarrhea in inoculated mice in a dose-dependent fashion. In one study (60), 0.1 
and 1.0 nmol of NSP4 caused diarrhea in 60% and 100% of the inoculated mice at 6 to 7 days of 
age, respectively. In 8- to 9-day-old mice, 0.1, 1.0, and 5.0 nmol of NSP4 caused diarrhea in 0%, 
60%, and 80% of mice, respectively. Another study demonstrated that mutations in NSP4 altered 
the pathogenicity of virus (61). The virulent OSU (OSU-v) strain of PoRV A (i.e., wild type) 
caused diarrhea in 89% of the inoculated mice whereas an attenuated OSU (OSU-a) rotavirus 
strain with six mutations in NSP4 did not cause diarrhea in mice. Furthermore, 5µg of 
recombinant OSU-v NSP4 caused diarrhea in 56% of the inoculated mice whereas the same dose 
of OSU-a NSP4 caused diarrhea in only 16% of the inoculated mice. 
Although a review article (62) states that group A and C rotaviruses are more virulent 
than group B rotavirus because they infect more cells causing more severe villous atrophy and 
diarrhea, comparison of the pathogenicity of PoRV A, B and/or C has not been reported in 
refereed publications. Information on the pathogenicity of rotavirus E and H is not available as 
rotavirus E was reported only in England and rotavirus H has been identified recently. 
III. Clinical manifestations 
The incubation time varies by various factors but generally ranges from 18 to 96 hours 
after exposure in piglets. Common clinical signs observed in piglets infected with rotavirus are 
anorexia, depression, diarrhea, and vomiting. Occasionally infected piglets also show elevated 
body temperature (21). Diarrhea in affected animals is characterized as follows: “Feces were 
watery to creamy consistency and white, yellow, or brown, similar to that observed in 
transmissible gastroenteritis (TGE).”(48). The severity of diarrhea induced solely by rotavirus is 
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mild and lasts for 1 to 3 days. Dehydration is also mild (48, 63). While morbidity is about 20% 
(21) or 50-80% (64) , the mortality among diarrheic dehydrated piglets is up to 15-20% (21, 48). 
Rotavirus infection is generally subclinical in pigs older than 3 months of age although diarrhea 
and vomiting can be sometimes observed in older pigs (64).  
Clinical signs of rotavirus infection in experimentally inoculated pigs have been more 
severe than those in naturally infected ones. The reason may be that most of experimental studies 
used gnotobiotic or cesarean-derived, colostrum-deprived (CDCD) pigs which lack maternal 
immunity. Under experimental conditions, neonatal piglets (1- to 5-day old) develop much more 
severe diarrhea, lasting for 4-8 days, followed by dehydration as compared to older pigs (7- to 
21-day old). The mortality rate in piglets with dehydration can reach up to 50–100% (65, 63, 43) 
while no or low mortality can be observed in the older pigs (66, 67, 49). 
Co-infections with other enteric pathogens are not uncommon in pigs infected with 
rotavirus in the field. Escherichia coli, Isospora suis, Clostridium.difficile, and porcine 
reproductive and respiratory syndrome virus (PRRSV) have been identified in sucking piglets 
infected with rotavirus (68, 69). In pigs with concurrent infections, clinical signs have been more 
severe in terms of the severity and duration of diarrhea, degree of dehydration, and mortality rate 
(70, 71). In addition, concurrent infections with rotaviruses of different groups have been 
reported. (72). However, clinical significance of infection with multiple groups of rotavirus for 
the disease and pathology has not been studied. 
Grossly, affected pigs have thin-walled small intestine containing yellowish or gray fluid, 
which is similar to gross lesions observed in pigs affected by TGE (48). A typical microscopic 
lesion in pigs infected with porcine rotavirus group A (48, 73),(74), group B (75) or group C (44) 
is villous atrophy. Blunted and shortened villi, which are only 1/10 to 1/4 long compared to the 
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normal ones, are covered with cuboidal and squamous epithelial cells. Subsequently, the villi 
fuse with adjacent ones (76). The crypts are deepened due to hyperplasia of crypt cells. For 
group A rotaviruses, lesions are mostly found in jejunum and ileum, which have also been 
corroborated by experimental infection studies (48, 49, 77) . A review (59) stated that lesions in 
pigs infected with a rotavirus B or C can be present throughout the small intestine. 
IV. Immunity 
There have not been many studies on pig immunity against porcine rotavirus. Almost all 
of the studies conducted in pigs used human rotaviruses; hence observations may not exactly 
mirror porcine rotavirus immunity. In particular, information regarding the innate immunity 
against rotaviruses in pigs is sparse. 
4.1 Innate Immunity 
Plasmacytoid dendritic cells collected from pigs inoculated with a HRV have shown to 
produce a high amount of interferon alpha (IFN-α) found in serum, which was independent of 
the virus doses (78). In the same study, a lower amount of interleukin-12 (IL-12) and a minimal 
amount of IL-10, tumor necrosis factor-alpha (TNF- α), and IL-6 were also found in serum. In 
another study, the severity of HRV-associated clinical signs was reduced by enhancing activity 
of plasmacytoid dendritic cells, natural killer cells, and IL-12 response (79). IFN-α and IFN-γ 
have been shown in vitro that they can inhibit HRV A (Wa strain) infection in Caco-2 cells, 
reducing its infectivity to 10% and 1%, respectively, in the cell measured by immunoperoxidase 
staining. However, IFN-γ, not IFN-α, was shown to inhibit the virus entry to Caco-2 cells, 
suggesting that IFN-γ and IFN-α have different mechanisms to inhibit the virus infection (80). 
Nonetheless, the antiviral role of IFN-γ against rotavirus in vivo has not been clear in a mouse 
and pig model (78, 81).  
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It has been reported that rotaviruses can modulate the innate immunity. Type I IFN 
production can be inhibited by viral NSP1 protein as NSP1 has shown to degrade IFN regulatory 
factor 3, 5,7 (82, 83) and inhibit NF-ĸB activity (84) by stimulating the degradation of β-TrCP 
(85). In addition, the antiviral state which is induced by IFN can be inhibited by rotavirus 
because STAT1 (signal transducer and activator of transcription) phosphorylation and 
STAT1/STAT2 nuclear translocation have been shown to be inhibited by rotavirus infection 
(86,87).  
4.2 Adaptive immunity 
Both passive and adaptive immunity plays an important role in protection against 
rotaviruses. Neonatal pigs can have maternally derived passive immune protection from the 
dams through colostrum or milk that contain mainly IgG and IgA, respectively. According to 
Ward (88), piglet receiving colostrum containing rotavirus-specific IgG whose concentration is 
approximately a half of those in naturally sucking piglets could mitigate the clinical signs by 
rotavirus infection and had fast recovery. Similarly, gnotobiotic piglets that received immune 
serum intraperitoneally (18 to 26 mg of IgG per 1 ml) or colostrum and milk have a significant 
lower rate of diarrhea and lower level of virus shedding than those in control groups (89). 
To assess the role of B cells and CD8+ T cells in anti-rotavirus immunity, genetically-
modified pigs were used (90). The pigs were manipulated to have CD8 cells depleted and/or to 
be defective in immunoglobulin heavy encoding gene (HCKO), which hinders B-cell 
development. These pigs along with wild-type pigs were first vaccinated with an attenuated 
HRVA Wa strain and at 28 days later were challenged with a virulent strain of the same virus. 
The HCKO defective pigs had significantly longer virus shedding than did the wild-type pigs. 
Furthermore, HCKO defective/CD8 depleted pigs had significantly longer duration of diarrhea 
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and virus shedding than did the wild-type pigs. These results suggest that both B cells and CD8+ 
T cells are important in anti-rotavirus immunity. 
In piglets infected with the PoRV A Gottfried strain, IgM antibody secreting cells (ASCs) 
were detected in mesenteric lymph node (MLN) at 3 dpi and the number of these cells in MLN 
and spleen researched to the peak at 7 dpi. IgA ASCs were first detected at 7 dpi in MLN, spleen, 
and lamina propria of duodenum and ileum. The peak numbers of these cells were found at 14 
and 21 dpi in duodenum lamina propria. IgG ASCs were first detected at 7 dpi in MLN, spleen, 
and lamina propria of duodenum and ileum and peaked at 14 dpi in spleen and duodenum lamina 
propria. At 14 and 21 dpi, the number of IgA ASCs were higher than that of IgG and IgM ASCs 
in MLN and lamina propria of duodenum and ileum. In another pig study with SB1A strain of 
PoRV A, the numbers of IgA and IgG ASCs in the intestinal lamina propria were 21- and 1.4-
fold, respectively, higher than those in the spleen (91). When pigs were orally inoculated with a 
HRV A isolate, a positive correlation between acquired protection and the level of lymphocyte 
proliferation as well as the number of cells secreting IgA in the small intestine was observed, 
suggesting that intestinal immune response is crucial to anti-rotavirus protective immunity. 
According to Azevedo (92), both intestinal IgA and serum IgA were correlated with protection 
against virus shedding and diarrhea, suggesting that rotavirus-specific IgA antibody is a good 
indicator of protective immunity.  
It has shown thatVP4- and VP7-specific antibody can protect pigs from virus challenge 
(93) because VP4  and VP7 (94) contain neutralizing epitopes (95). Pigs recovered from prior 
rotavirus infection are totally protected from subsequent challenge with a homotypic, but not 
heterotypic, rotavirus (93). The cross-protection between serogroups or serotypes is trivial if not 
none. However, it has been reported that repeated infection or vaccination even with the same 
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strain can broaden the degree of cross-protection between serotypes (96, 97). It is speculated that 
neutralizing epitopes in VP4 are independent from those in VP7 (98) and some may be cross-
reactive (99). Thus, humoral immune response against these epitopes can be boosted after 
repeated infection or vaccination. Nonetheless, the determinant for heterotypic protection is still 
unclear as the neutralizing epitope(s) that are in common of serotypes or genotypes have not 
been identified.  
 After infection or vaccination, pigs have shown to produce VP6-specific antibody to a 
significantly higher level than those against VP4, NSP4, NSP2, and VP7. Although anti-VP6 
antibody has not shown to neutralize the virus or protect neonate piglets (92, 100), it was 
reported to be protective in mice (101-106). Furthermore, anti-VP6 IgA has shown to have the 
“intracellular neutralization” ability in vitro by interfering with viral transcription, which is not 
apparent in traditional neutralization tests (107, 108). Since not many studies have been 
conducted to assess the role of VP6 antibody-mediated immunity in protecting pigs, its anti-
rotavirus ability remains to be further studied. 
Because NSP4 of rotavirus has shown an important role in the viral pathogenesis as 
discussed above, the role of anti-NPS4 immune response in protection against rotavirus has been 
of great interest. When infected with PoRV A (109), piglets had a significant higher titer of anti-
NSP4 IgG than anti-NSP4 IgA in serum. However, these antibodies could not protect these 
piglets from subsequent challenge with the viruses with different G (VP7) and P (VP4) but 
mostly identical NSP4 three weeks after the primary infection, suggesting that NSP4 antibody 
may not play an important role in anti-rotavirus protective immunity. Another study (110) 
showed a positive correlation between NSP4 antibody and protection when piglets were 
challenged and re-challenged with the same virulent HRV isolate. It is, however, difficult to 
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extrapolate the exact role of NSP4 antibody in protection from this study as the role of antibody 
against other viral proteins in the protection could not be ruled out due to the fact that the same 
virus was used in both primary and secondary challenges. Nonetheless, in a mouse study, NSP4 
antiserum demonstrated its ability to protect mice from developing diarrhea (111). Therefore, it 
remains to be further investigated to clarify the role of anti-NSP4 antibody in protection against 
rotavirus. 
V. Diagnosis and Diagnostics 
5.1 Sampling and diagnosis  
Rotavirus-associated diarrhea can be preliminarily diagnosed by disease history of the 
farm, pig age (nursing, post-weaning), clinical signs, and gross lesions. Common clinical signs 
and gross lesions which can be observed with rotavirus infection are described above. 
Subsequently, samples, such as feces, intestinal contents, or small intestinal tissues, should be 
collected for laboratory testing such as nucleic acid detection methods (PCRs), histopathology, 
and antigen detection methods (i.e., immunohistochemistry, immunofluorescence). It is best to 
collect samples within 24 hours after diarrhea is seen because the rotavirus shedding generally 
reaches the peak at this time (21). 
Diarrhea in piglets can be attributed to many microbial agents, environmental and 
nutritional factors. The differential list for infectious diseases in nursing pigs (i.e., pre-weaning 
piglet diarrhea) should include Escherichia coli, Clostridium difficile, Clostridium perfringens 
type A and C, Enterococcus durans, Salmonella spp, Isospora (coccidia), Cryptosporidia parvum, 
porcine epidemic diarrhea virus (PEDV), and transmissible gastroenteritis virus (TGEV), and 
PRRSV. The differential list for infectious diseases in weaning pigs (i.e., post-weaning diarrhea) 
include: E. coli, Salmonella spp., Brachyspira spp. Lawsonia intracellularis, Coccidia, 
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roundworms, whipworms, TGEV, PEDV, PRRSV, porcine circovirus. 
(https://vetmed.iastate.edu/sites/default/files/VDL/pdf/porcinepathologyguides.pdf) 
5.2 Laboratory methods 
Various conventional and advanced laboratory methods have been developed and used to 
detect the presence of virus and virus-specific antibodies in clinical specimens. Historically, 
isolation of rotavirus has been difficult and very laborious. Because of that nature, while 
visualization of virus presence in feces was commonly used for rotaviruses like many other 
enteric viral pathogens, nucleic acid-based tests have become a common tool recent days. 
5.2.1 Virus detection 
Because rotavirus is shed in feces with a high amount, up to 109 particles per ml (74) and 
the morphology is unique, electron microscopy (EM) is applicable to visualize the presence of  
rotavirus in feces or intestinal contents (112). Although it is laborious and expensive and requires 
experienced personnel for sample preparation and to operate the instrument, EM is considered a 
quick test. Serogroups of rotaviruses can be differentiated by immune EM using serogroup-
specific antibodies (i.e., anti-VP6 antibody for each serogroups/types).  
Rotavirus isolation by cell culture has been challenging. From pigs, rotavirus was first 
isolated in 1976 (113). In this instance, diarrheic feces were first inoculated in 2- to 28-day-old 
gnotobiotic pigs. Subsequently, the feces containing the virus were inoculated in primary calf 
kidney and pig kidney cells. The cytopathic effect (CPE) and virus-specific immunofluorescent 
staining were observed in the first passage of cell culture. However, this result was not 
reproducible in subsequent passages, indicating that this culture system was not suitable or 
optimized for propagating rotavirus. In 1977, several cell culture based virus isolation attempts 
were made for bovine (114), porcine (115) and human (116) rotaviruses. In those studies, a roller 
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culture technique and/or incorporation of proteolytic enzyme (i.e. trypsin, pancreatin) into cell 
culture media were used with successful isolation of group A rotaviruses. Numerous kidney 
epithelial cells, such as Madin-Darby bovine kidney (MDBK), calf kidney cells, rhesus monkey 
kidney epithelial cells (LLC-MK2), and primary pig kidney cells, were found to be permissive to 
rotaviruses. Since then, African green monkey cell line MA-104 was adopted and has been 
widely used for rotavirus isolation, particularly for RVA (117,118, 119, 120, 121,122). 
Pretreatment of inoculums with a proteolytic enzyme or adding the enzyme to a culture medium 
and use of roller culture have been vital conditions for the successful virus isolation. 
 Successful isolation of non-group A porcine rotaviruses are rare. To date, isolation of 
only one PoRV B has been reported by Japanese scientists (123), but there is no further 
information of this virus isolate. For group C porcine rotavirus, all the reported work used one 
virus strain, Cowden (124, 125). This virus strain was first isolated using primary pig kidney 
cells cultured in media supplemented with pancreatin in roller tubes; however, details of 
materials and conditions are lacking. The viral infectivity, which was assessed by 
immunofluorescence microscopy of inoculated cells, increased intensely after six passages. 
Subsequently, the virus was successfully adapted to grow in MA-104 cells in roller culture, not a 
stationary culture. Although this protocol for isolating PoRV C was available, no more PoRV C 
isolates have been made since the Cowden strain was isolated. Furthermore, the method is 
complicated by the necessity of numerous blind passages in two different cells for primary 
isolation and adaptation. It is necessary to identify more sensitive cell culture systems for non-
group A porcine rotavirus isolation. Recently, non-transformed intestinal IPEC-1 and IPEC-J2 
cells which were originated in small intestine of 1-day old piglets have been used in studying 
enteric viral pathogens such as TGEV and PEDV (126), and PoRV A (127). Thus, IPEC-1 and 
20 
 
 
IPEC-J2 cells might be candidate cell lines to be evaluated in attempting to isolate non-group A 
rotaviruses. 
5.2.2 Antigen detection 
Historically, immunofluorescence test has been commonly used to detect rotavirus A 
antigens in frozen intestinal tissue sections (128) and has also applied to detect rotavirus B and C 
in paraffin-embedded intestinal tissues (44, 75). The sample quality has been an issue as 
intestinal tissues can be easily decomposed. As monoclonal antibodies were developed and 
became available (129, 130), an immunohistochemical staining method was developed to detect 
RVA antigens in formalin-fixed and paraffin-embedded tissues (131) and has become a standard 
tissue assay to demonstrate the presence of rotaviruses, particularly for rotavirus A. However, 
such a virus-specific monoclonal antibody for non-group A rotaviruses is lacking.  
Some antigen-capturing ELISAs (ACEs) using a microtiter plate had been developed to 
detect rotavirus antigen of rotavirus A (132, 133), B (134), and C (135) in feces under 
experimental conditions. However, only group A rotavirus-specific ACEs is commercially 
available, mostly for use in human medicine (136). Also, commercial latex agglutination kits 
have been available to detect rotavirus A antigens in feces (136). Recently commercial kits for 
veterinary use have also been made available in the US and/or other countries, such as Pig 
Rotavirus Group Specific Antigen ELISA Kit-LS-10367 (LSBio, Seattle, WA) and Pig Rotavirus 
Antigen ELISA Kit (Flarebio Biotech LLC, College Park, MD). However, the performances of 
these kits have not been evaluated by independent investigators. 
 Although infections with non-group A porcine rotaviruses in young pigs are frequent, 
reagents specific for these viruses, such as monospecific antibodies, are lacking, which hinders 
the development of laboratory methods such as immunohistochemistry (IHC) or ACE.  
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5.2.3 Viral genome detection 
While RNA electrophenotyping was commonly used to characterize rotaviruses, 
Northern blot techniques using virus-specific hybridization probes were used to detect rotaviral 
genomic RNA or mRNAs in clinical specimens (137, 138, 139). Subsequently, polymerase chain 
reaction (PCR)-based assays have been widely used to detect the presence of rotavirus RNA in 
clinical specimens including feces. These assays have also been useful for rapid genogrouping 
and genotyping (i.e., G or P types) for rotavirus A (140, 141, 142), B (143,13), and C (143, 16).  
Recently, a real-time RT-PCR panel which can detect the nucleic acid of PoRV A, B and C has 
been developed (72) and adapted by many veterinary diagnostic laboratories for the rotavirus 
detection as it could provide  simultaneous detection of 3 serogroups and a high-throughput 
capability. In addition, the real-time RT-PCR assay has also been used in a quantitative manner 
to estimate the level of rotavirus in a specimen, which aids in “feedback” practice to mitigate the 
disease or boost the herd immunity against selected strains of rotaviruses. 
The availability of viral sequences in public domains (e.g., GenBank®) and advances in 
technology allows laboratories to utilize sequencing for VP4, VP6 and/or VP7 genes for 
genotyping and molecular characterization of rotaviruses.  
5.2.4 Antibody detection 
Since rotaviruses are common in swine herds, detecting anti-rotavirus serum antibody has 
little diagnostic value. Nevertheless, the status of the infection in the pigs can be assessed by 
determining the isotype of the antibodies. The recent or active infection is indicated by detecting 
high titer of IgM or IgA. Evidence of previous exposure and vaccination status in a population 
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can also be assessed by serology. In some cases, neutralizing antibodies have been measured 
using fluorescent focus reduction assay (144) or plaque reduction assay (145) to assess possible 
antiviral immune status against PoRV A. 
Several ELISAs were developed to isotype the antibody against human rotaviruses A in 
pig sera, which were used in research (92,144,146).  In addition, an ELISA was developed to 
detect antibodies against PoRV A (147). An ELISA detecting PoRV C antibody has been 
described (148). No commercial ELISA to detect antibodies of PoRV B or PoRV C is available.  
VI. Epidemiology 
The presence of rotaviruses has been widely detected in pig producing regions worldwide. 
The economic lost caused by rotavirus infection is considered moderate (149) even though 
rotaviruses do not cause as severe disease as does TGEV or PEDV. Yet, cost analysis of 
rotavirus-associated enteric disease in the swine industry has not been performed.  
Rotaviruses are believed to be ubiquitous in swine herds because the virus is shed with a 
high amount in feces and their resistance to various environment conditions. The prevalence of 
group A porcine rotavirus ranges from 2.5 % to 78.7%, while those of group B and C porcine 
rotaviruses are up to 25.9% and 78.0%, respectively. The variability of prevalence is attributed to 
differences in geographic locations, ages of pigs tested, tests that were used, and sampling 
scheme (i.e., random fecal samples from general populations or diarrheic fecal samples) as 
shown in Table 6.  
Pigs are frequently found to be infected with multi-groups of rotaviruses, which makes 
the prophylaxis more challenging. According to unpublished data from the Iowa State University 
Veterinary Diagnostic Laboratory, PoRV A tend to be prevalent in 3- to 6-week-old piglets 
(post-weaning ages), whereas PoRV B have been detected equally in all ages although more than 
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50% of rotavirus B positives were in 3 weeks or older pigs, and PoRV C have been most 
frequently detected in neonates and suckling piglets (pre-weaning). This pattern is similar to the 
results of a diagnostic laboratory-based survey study by the University of Minnesota Veterinary 
Diagnostic Laboratory which tested a large number of samples (n=7508) by PCR-based assay 
(72). As the frequency of various rotavirus serogroups observed among diarrheic pigs shows a 
tendency of different age distribution, it could be speculated that the pathogenicity or 
pathogenesis of rotavirus A, B, and C may differ in suckling piglets and older/adult pigs. 
However, no experimental data supporting this speculation is available. 
Because a high level of rotavirus can be shed in feces from affected pigs, the fecal-to-oral 
route is widely accepted as the main transmission pathway of rotavirus among pigs as well as 
between other species. Because of this nature, most of experimental rotavirus challenge studies 
have used the oral route to inoculate  pigs with feces containing the virus (65, 42, 63, 150, 151, 
152, 75, 49, 77, 43, 54, 153, 154, 155). At barns, pigs are believed to be exposed to rotavirus via 
pig-to-pig contact or from contaminated environment such as floor. The facts that rotaviruses can 
be detected in feces from asymptomatic pigs (156, 157, 158, 159) or pregnant sows 5 days 
before to 14 days after farrowing (160) makes it rather difficult to intervene the virus 
transmission at a barn or on herd. Furthermore, since rotaviruses can maintain their infectivity in 
environmental water for several days at 20°C (161), rotavirus-contaminated water may also be a 
source of virus transmission.  
Besides the fecal-to-oral route transmission, aerosol transmission has been postulated. It 
was reported that rotavirus can infect mice through aerosol and the antigen was detected in 
mouse lungs by antigen-capture ELISA up to 8 days after infection (162). In the Mid-Pacific 
island, HRV caused diarrhea and was transmitted quickly among peoples, raising a concern that 
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the virus may be transmitted through respiratory route (163). In another study (54), gnotobiotic 
piglets intranasally inoculated with an attenuated HRV under experimental conditions could shed 
the virus in nasal secretions. And the piglets also shed virus nasally when they were experimental 
inoculated with a virulent HRV isolate orally, intranasally or via gavage. Thus, air or aerosol 
spreading is a potential transmission route of rotavirus although this transmission mode has not 
been proven in pigs.  
Rodents and insects have been proposed as potential vectors for transmission of 
rotaviruses. Rotavirus A was detected by ACE in the feces from mice and rat trapped in a pig 
farm (164), suggesting that mice could play a role in rotavirus transmission. However, it was not 
determined whether the detected virus was a porcine rotavirus. In another study, 1.1% of rodents 
trapped in two cities in China were positive for rotavirus. A half of the positive samples had 
rotaviruses with the same P and G type as those detected in human populations in the cities based 
on sequence analysis (165). In addition, flies were demonstrated to be able to carry a simian 
rotavirus A (SA11 strain) on their legs, potentially serving as mechanical vector (166). Besides 
rodents and insects, wild boars have been proposed to be involved in rotavirus transmission to 
domestic swine as many group A rotaviruses detected by PCR assay in feral swine share the 
same P and G types of group A rotaviruses found in domestic swine in the same geographic 
regions as determined by sequence analysis (167). There is no information about the 
transmission of PoRV through feed contamination or boar semen. 
Pigs are the natural host of porcine rotaviruses. However, cross-species transmission has 
been documented. Either whole genomes or some gene segments of PoRVs have also been 
sporadically detected in sick humans, cattle and horses (168, 169, 170, 171, 172, 173, 174, 175, 
176, 177, 178, 179, 180). A porcine rotavirus-like rotavirus isolated from a clinically ill cow 
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could cause diarrhea in both piglets and calves for up to 14 dpi after experimental exposure (181), 
indicating that rotavirus can cross the species barrier. Cross-species transmission has also been 
made with bovine rotaviruses (182, 183,184,185,186, 187,188,189, 190, 191,192). There have 
been a growing number of reports describing children patients (less than 5 years old) infected 
with a PoRV-like (170, 172,173,174, 177) or bovine rotavirus-like rotavirus (185, 191), 
suggesting that rotavirus is a potential zoonotic agent.  
In feces, PoRV A was reported to be able to maintain its infectivity for 32 months at 
10°C (193) while HRV A could maintain its infectivity for 2.5 months at 30°C (194), suggesting 
that rotavirus survives better at a low temperature. The HRV A (Wa strain) was shown to survive 
longer in non-porous materials (e.g., glass, stainless steel, plastic) than in porous materials (e.g., 
cloth, poster card, paper), indicating that a low humidity may be detrimental to rotavirus 
infectivity (195). Overall, rotaviruses can survive longer in a lower temperature and high 
humidity environment. Isolation of rotavirus A from dust in the nursery which had not been used 
to house pig for 3 months has been reported, suggesting that infectious rotavirus can be remained 
in dust for a long time (196). While all these findings confirm that rotavirus is sturdy in the 
environment, the stability of rotavirus in natural water bodies may be different. A study reported 
(161) that the time taken to diminish 103 PFU of the simian rotavirus SA11 strain at 20°C was 2-
3 days in estuarine water but 3 to >14 days in fresh water; however, the same observation could 
not made between two water types when sampling was made one year later, suggesting that the 
survival of rotavirus was independent of salinity. The authors postulated that seasonal changes 
may affect in the virus survival in natural waters but did not speculate any specific parameters 
including temperature. In another study (197), a HRV can stay for up to 64 days in filtered river 
water without a change in the titer, measured by plaque assay, at both 4°C and 20°C. In raw 
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unfiltered river water, the viral titer was decreased by almost 102 and 103 at 4°C and 20°C, 
respectively, after 15 days. The investigators speculated that there may have been an antiviral 
effect from the microorganisms present in the raw unfiltered water because the virus lost 99% of 
its original titer after 10 days in that water. Yet, this postulation remains to be confirmed.  
VII. Prevention and control 
7.1 Management 
Since rotaviruses are ubiquitous and sturdy, it is difficult to eradicate it from pig farms. In 
addition, a high titer of rotavirus is shed in feces from affected pigs which can overcome the 
maternally derived lactogenic passive immunity of piglets if they are exposed to the virus (198). 
Nonetheless, the risk for exposure and the disease severity can be reduced by strictly following 
biosecurity procedures as well as good management practices. The virus load can be reduced by 
implementing a good sanitation protocol. Rooms need to be cleaned and disinfected well 
between uses. The floor of rooms should be constructed for minimal fecal accumulation and 
efficient cleaning. Also, the shorter farrowing interval has been recommended to minimize the 
fecal accumulation and infection of latest farrowed litters (199). It is also recommended to keep 
the room at a warm and stable ambient temperature (35°C) to reduce the mortality of nursing 
piglets by rotavirus infection (200). Interestingly, a field-based study (201) showed that herds 
using all-in-all-out (AIAO) practice had a significantly higher rate of rotavirus infection as 
compared to herds using continuous flow. However, the herbs using AIAO also implemented an 
early weaning strategy. Thus, it is not clear that AIAO practice was the cause of higher rotavirus 
detection rate. Thus, the role of AIAO in rotavirus prevention and control is still questionable. 
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7.2 Medication and nutritional intervention 
There is no specific treatment for rotavirus infection. All therapies and management 
practices are supportive and to alleviate adverse effects of the disease. Antibiotics can be used to 
control co-infected bacterial agents or secondary bacterial infections in rotavirus-infected pigs. 
Dehydration and weight loss due to rotavirus-associated diarrhea can be lessened by using an 
electrolyte solution containing glucose-glycine (202), although supplying water with electrolytes 
to pigs while refraining from feed has been commonly practice on farms when diarrhea is 
noticed. In children, It has been reported that feeding of transforming growth factor to diarrheic 
piglets helps their jejunum villi recovered quicker from rotavirus-associated damages (203). 
Animal plasma protein has been shown to be useful and better than soy protein to speed up the 
recovery process and interfere with the virus infection because it contains growth factors and 
virus-binding proteins (204). Soy isoflavones, including genistein, can inhibit rotavirus 
replication in vitro (205,206); however, the effect in vivo is not known. 
Probiotics (i.e., beneficial bacteria) can be a good supporter. Pigs fed with Lactobacillus 
rhamnosus had milder diarrhea than those not fed (207). Lactobacillus reuteri showed its ability 
to prevent rotavirus from infecting MA-104 cells in vitro (208). Lactobacillus acidophilus has 
also been reported to act as an adjuvant to improve the efficacy of an attenuated rotavirus 
vaccine since pigs immunized with the vaccine supplemented with L. acidophilus had a higher 
number of intestinal IFN-γ-producing CD8+  T cells and intestinal anti-RV IgA and IgG 
secreting cells, and higher serum anti-RV IgA titers compared to those received the vaccine 
without L. acidophilus (209). 
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Vitamin A is believed to play an important role in the immune response to rotavirus or 
vaccines because gnotobiotic pigs with vitamin A deficiency showed weak innate or adaptive 
immune responses against HRV (210) or HRV vaccine (211, 212).  
7.3 Oral passive immunization, vaccination and feedback  
Chicken egg yolk antibodies (IgY) have been studied for rotavirus intervention. It has 
been reported that oral feeding of anti-RVA IgY can prevent or minimize diarrhea caused by 
rotavirus in gnotobiotic piglets (213), newborn calves (214), and mice (215). The protection 
mechanism of IgY may be inhibition of the virus binding to cell surfaces (216), preventing 
intercellular spread, immobilization of the microbes by agglutination, and/or neutralization of 
rotaviral enterotoxin (217, 218, 219). 
Vaccination has been practiced to protect piglets against rotavirus. Except PoRV A, there 
is no commercial vaccine for PoRV B or C. Vaccines have been used with two objectives. The 
first is to build lactogenic immunity in sows which can be passed onto newborn piglets. When 
pregnant or lactating sows were vaccinated with an attenuated PoRV A G5P[7], the titers of 
secreted IgA and IgG in the milk were increased, giving piglets born to those sows a partial 
protection against subsequent challenge such as delaying the onset of disease and shortening the 
duration of diarrhea and virus shedding. However, the efficacy of the commercial vaccines in the 
field is still questionable because rotavirus-associated diarrhea of piglets occurred in herds using 
vaccines (220). The current belief is that suboptimal efficacy of the vaccines may be attributed to 
antigenic mismatch between the vaccine strains and insulting viral strains as for VP7 (i.e., G 
types) and VP4 (i.e., P types). The second objective of vaccination is to induce active immunity 
in piglets. It has been demonstrated that inactivated rotavirus vaccines could not provide the 
protection to vaccinated pigs because it could not induce mucosal immunity in the intestine (221). 
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On the other hand, an attenuated live virus vaccine has shown to protect CDCD piglets from a 
challenge with homologous viruses under experimental conditions (221). However, the efficacy 
of the attenuated live virus vaccine may not be clear under field conditions (222) as the maternal 
antibody in nursing piglets has shown to neutralize the vaccine virus itself which was orally 
administered so that the vaccine virus could not replicate (89). A possible solution for this 
problem may be that the vaccine should be administrated orally multiple times. 
Since vaccines are not highly effective for PoRV A and are not available for PoRV B and 
C, an intentional exposure to a biological material containing rotavirus (also known as 
‘feedback’) has been used in pig farms. Fecal material or homogenized small intestine tissue 
from acutely affected piglets commonly serves as inoculum and given orally to animals. 
However, there is no information in literature relating standard procedures for preparing and 
administrating the feedback material and evaluating the efficacy of feedback. Microbiological 
safety is of great concern since unwanted microorganisms can be concurrently given along with 
rotavirus due to the nature of feedback materials. Strict biocontainment practice is required to 
prevent unintended transmission of rotavirus to animals or neighboring farms. 
VIII. Conclusion 
Rotavirus is common in pig farms causing diarrhea. Besides rotavirus A, rotavirus B and 
C have been detected frequently in diarrhea piglets. However, a few studies have been done 
specifically on non-group A rotaviruses for various reasons, resulting in a knowledge gap for the 
pathogenesis and immunobiology of the viruses and also lack of tools and specific reagents for 
better diagnosis, prevention and disease control. Much of these lacking have been attributed to 
the inability or difficulty to isolate non-group A rotaviruses, which requires a great attention for 
future development. Application of molecular biological techniques, including reverse genetics, 
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may hold a hope for some aspects, expecting a continuous difficulty in obtaining isolates of non-
group A rotaviruses through conventional virus isolation technique.  
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Table 
 
Table 1. Geographic distribution and estimated prevalence (in the parenthesis) of G and P types 
of porcine rotavirus group A 
 
Country Study year G types P types Predominant       
G/P types 
References 
Brazil 1995-1997 
(n=59*) 
G5 (37%) 
G3, G4 (9%) 
G9 (5%) 
P[7] (39%) 
P[6] (61%) 
G5 P[6] (10%) 
G5 P[7] (10%) 
(223) 
 
1991-1992 
(n=10) 
G4 (20%) 
G9 (20%) 
G1 (15%) 
G5 (5%) 
P[6] (50%) 
P[8] (10%) 
G4 P[6] (20%) 
G9 P[6] (20%) 
 
(10) 
Belgium 2014 
(n=17) 
G4 (29.4%) 
G5 (29.4%) 
G9 (23.5%) 
G3 (5.9%) 
P[7] (29.4%) 
P[6] (23.5%) 
P[23] (23.5%) 
P[13] (11.8%)  
G4 P[6] (17.6%) 
 
(224) 
Canada 2005-2006 
(n=13) 
G4 (55%) 
G5 (18%) 
G2 (9%) 
G9 (9%) 
G11 (9%) 
P[6] (64%) 
P[13] (15.3%) 
P[27], (15.3%) 
G4 P[6] (45%) (225) 
2011-2012 G2 (59%) 
G11 (22%) 
G5 (20%) 
P[13] (64%) 
P[27] (23%) 
P[34] (13%) 
P[6] (10%) 
G2 P[13] (157) 
England 
 
2009-2010 
(n= 654) 
 
G4 (29.8%) 
G5 (27.5%) 
G2 (6.7%) 
P[32] (55.2%) 
P[7] (28%) 
P[6] (11%) 
G4 P[32] (18.6%) 
G5 P[32] (13.5%) 
(226) 
Korea 2006-2007 G5 (70%) 
G8 (17%) 
G9 (9%) 
P[7] (93%) 
P[23] (2%) 
P[1] (1%) 
G5 P[7] (64%) (227) 
Japan 2000-2002 G9 (33%) 
G5 (18%) 
G3(11%) 
G4, G1 
P[6] (28%) 
P[23] (28%) 
P[7] (17%) 
G9 P[23](17%) (228) 
Poland 2002? 
(n=88) 
G5 (25%) 
G4 (16%) 
G3 (9%) 
P[7] (25%) 
P[6] (16%) 
 
 (229) 
Slovenia 2004-2005 
(n=81) 
G5 (30%) 
G3 (27%) 
G4 (19%) 
G1,G2,G6,G10, 
G11 
P[6] (41%) 
P[13] (17%) 
P[7] (16%) 
G3 P[6] 
G5 P[7] 
G4 P[6] 
(230) 
USA 
 
2004-2012 
(n=23) 
G9 (78.2%) 
G4 (8.6%) 
G11 (8.6%) 
P[7] (13%) 
P[13](78.2%) 
G9 P[13] (60.9%) (231) 
 
 
2002? 
(n=31) 
G4 (32%) 
G5 (29%) 
P[7] (55%) 
P[6] (42%) 
 (229) 
1985-1992 
(n=57) 
G11 (52%) 
G4 (35%) 
G5 (15%) 
 
P[7] (33%) 
P[6] (10%) 
 (232) 
*The number of samples collected for testing when provided. 
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Table 2. Genotypes of rotavirus A (updated from reference 233) 
 
Name of genotypes Gene 
product 
Cut-off percent 
nucleotide identity 
Number of 
genotypes 
G (Glycosylated) VP7 80% 28G 
P (Protease sensitive) VP4 80% 39P 
I (Inner capsid) VP6 85% 21I 
R (RNA-dependent RNA) polymerase VP1 83% 14R 
C (Core protein) VP2 84% 14C 
M (Methyltransferase) VP3 81% 13M 
I (Interferon Antagonist) NSP1 79% 24A 
N (NTPase) NSP2 85% 14N 
T (Translation enhancer) NSP3 85% 16T 
E (Enterotoxin) NSP4 85% 21E 
H (pHosphoprotein) NSP5 91% 16H 
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Table 3. Geographic distribution and estimated prevalence (in the parenthesis) of G and P types 
of porcine rotavirus group B 
 
Country Study year G types P types References 
India 2016 G7 (33%) 
G19 (17%) 
G20 (33%) 
G21 (17%) 
N/A* (12) 
Japan 2000-2007 
 
G3 (21%) 
G4 (2.7%) 
G5 (76.3%) 
N/A (13) 
USA 2009 G6, G8, G10, G11, 
G12, G14, G16, 
G17,G18, G20 
N/A (14) 
Brazil 2016 G14 N/A (234) 
* N/A = not available 
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Table 4. Geographic distribution and estimated prevalence (in the parenthesis) of G and P types 
of porcine rotavirus group C 
 
Country Study year G types P types Predominant 
G/P 
Reference 
Belgium  G1 (8.3%), G6 
(66.7%) 
N/A N/A* (224) 
Czech 2010-2013 
n=7 for G types 
n=5 for P types  
G6 (28.5%) 
G1,3,5,7,10 
(14.3%) 
P[6],[8] (40%), 
P[2] (20%) 
N/A (235) 
Korea 2004-2012 
n=26 for G types 
n=9 for p types 
G7 (34.6%) 
G3 (30,8%) 
G6 (23,1%) 
G1 (11,5%) 
P[1] (11%),   
P[4] (11%),  
P[5] (22%),  
P[6] (22%),  
P[7] (34%) 
 (19) 
Japan 2000-2007 
n=22 for G type 
n=21 for P type 
G6 (45.5%) 
G1 (22.8%) 
G9 (22.8%) 
G2 (9%) 
P[5] (38%) 
P[4] (38%) 
P[6] (19%) 
P[1] (5%) 
G6 P[5] 
(27.3%) 
(18) 
USA 2009-2011 
n=70 
 
 
 
G6 (70%) 
G5 (17.2%) 
G1 (11.4%) 
G9 (1.4%) 
 
 
 
 
 
N/A 
N/A (17) 
 
 
 
2004,2011,2012 
n=25 
G6 (28%) 
G4 (28%) 
G1 (20%) 
G2,3,5 (8%) 
N/A N/A (236) 
*N/A = not available 
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Table 5. Information of genome fragments and their corresponding proteins adapted to bovine 
rotavirus RF strain (G6P6[1]). (233) 
 
Genome 
segment 
Size 
(bp) 
Encoded 
protein 
Size 
(kDa) 
Location in 
virion 
Molecules/virion Functions* 
1 3302 VP1 125 Core 12 RdRp; ssRNA binding; complex 
with VP3 
2 2687 VP2 94 Core 120 Core shell; RNA binding; required 
for RdRp activity 
3 2592 VP3 88 Core 12 Guanylyltransferase; 
methyltransferase; 2 ,5 -
phosphodiesterase; ssRNA binding; 
complex with VP1 
4 2362 VP4 86 Outer layer 180 Homotrimer; P type neutralization 
antigen; 
5 1581 NSP1 58 Nonstructural  Interferon antagonist; E3 ligase; 
RNA binding 
6 1356 VP6 44 Middle layer 780 Homotrimer, species determinant; 
protection (intracellular 
neutralization); required for 
transcription 
7 1062 VP7 37 Outer layer 780 Homotrimer; glycoprotein; G type 
neutralization antigen; Ca2+ 
dependent 
8 1059 NSP2 36 Nonstructural  Octamer; binds RNA, NTPase; NDP 
kinase; helix destabilizing; essential 
for viroplasm formation 
9 1074 NSP3 34 Nonstructural  Dimer; binds to: 3 terminus of viral 
ss (+) RNA, cellular eIF4G, Hsp90; 
displaces PABP; inhibits host protein 
translation 
10 751 NSP4  Nonstructural  RER transmembrane glycoprotein; 
viroporin; intracellular receptor for 
DLPs; interacts with viroplasms and 
autophagy pathway; modulates 
intracellular Ca2+ and RNA 
replication; enterotoxin (secreted); 
virulence 
11 666 NSP5 21 Nonstructural  Dimer; phospho- and O-glycosylated 
protein; RNA binding; kinase; 
essential for viroplasm formation; 
interaction with VP2 
NSP6 12 Nonstructural  Interaction with NSP5, localized in 
viroplasm 
*Abbreviations: 
RdRp: RNA-dependent RNA polymerase 
ssRNA: single-stranded RNA 
eIF4G: Eukaryotic translation initiation factor 4 G  
Hsp: Heat shock protein 
PABP: Poly(A)-binding protein 
RER: Rough endoplasmic reticulum 
DLP: Double-layered particle 
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Table 6. Geographical distribution and reported prevalence of rotaviruses. 
 
Country Assay used Pig ages 
# of positive/ 
total 
% positive for respective type 
References 
A B C Mix 
USA 
 
PCR 1-3 days 779/954 17% (133/779) 3.6% (28/954) 56.8% (443/779) 22.6 (175/779) (72) 
4-20 days 1580/2144 26.7% (422/1580) 3.3% (52/1580) 32.3% (511/1580) 37.6% (595/1580) 
21-55 days 2354/2538  21.8% (513/2354) 2.2% (56/2354) 3.7% (88/2354) 72.3 (1697/2354) 
>55 days 989/1207 19.8% (196/989) 9.1% (90/989) 8% (79/989) 63.1% (624/989) 
PCR Nursing and weaned 35/371 7% (26/371)  N/A N/A (231) 
PCR Nursing (<21 d) 56/70 15.7% (11/70) 12.9 % (9/70) 37.1 % (26/70) 14.3% (10/70) (14) 
Weaned (21-55 d) 78/81 2.5% (2/81) 2.5% (2/81) 3.7% (3/81) 87.6% (65/81) 
Finishing (>55 d) 22/22 18.2% (4/22) 0% 0% 81.8% (18/22) 
PAGE Nursing 68/146 76.4 % (52/68) 7.4 % (5/68) 7.4%  (5/68) 8.8%  (6/68) (237) 
Weaned 22/146 40.9%  (9/22) 18.2%  (4/22) 22.7%  (5/22) 18.2% (4/22) 
PCR ≤3days    78% (442/568)  (17) 
4-20days    65% (466/722)  
21-55days    6% (84/1447)  
>55days    14% (61/443)  
PCR Mostly <3 weeks 74/380   19.5% (74/380)  (236) 
Vietnam PCR  178/730 24.38% 
(178/730) 
   (238) 
East Africa PCR Total 117/446     (239) 
     Nursing 78.7% 
     Weaned 32.9% 
     Grower 5.8% 
Canada PCR Finisher (normal 
feces) 
48/98 49% (48/98)    (157) 
Korea PCR Diarrheic fecal 182/475 38.3% (182/475)    (227) 
36/137   26.2% (36/137)  (240) 
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Table 6 (continued)
Country Assay used Pig ages 
# of positive/ 
total 
% positive for respective type 
References 
A B C Mix 
Ireland PCR Weaned and 
grower, 
asymptomatic 
19/292 6.5% (19/292)    (158) 
PCR Weaned and 
grower, 
asymptomatic 
 
 
13/292   4.4% (13/292)  (159) 
 India PAGE Diarrheic feces 9/35 25.71% (9/35)    (241) 
PCR Feces 9/187  4.8% (9/187)   (12) 
Italy PCR Diarrheic feces 54/188   28.7% 
(54/188) 
 (242) 
Japan PCR <21 days 104/155 67.1% (104/155)    (68) 
>21 days 51/155 32.9% (51/155)    
PCR Diarrhea 190/735  25.9% (190/735)   (13) 
Brazil PAGE 
EIA 
<60days, Diarrhea 117/451  
 
25.94% (117/451)     (156) 
Not diarrhea 45/299 15.05% (45/299)    
ELISA 
PAGE 
Diarrhea 62/302 20.5% (62/302)    (243) 
New Zealand PAGE   18.4% (28/152) 0.65% (1/152) 5.9% (9/152)  (244) 
Czech PCR Total 75/293     (245) 
     Nursing 22.3% (21/94) 
     4-8 weeks 35% (7/20) 
     8-12 weeks 34.5% (10/29) 
     Sows 12.5 % (9/72) 
     Boars 0% (0/5) 
     Finisher 38.4% (28/73) 
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Figure 
 
Figure 1. Microphotograph of PoRVC particles in feces visualized by negative-staining electron 
microscopy  
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Figure 2. Architectural features of rotavirus virion. (A) PAGE gel showing, 11 dsRNA segments 
comprising the rotavirus genome. The gene segments are numbered on the left and the proteins 
they encode are indicated on the right. (B) Cryo-EM reconstruction of the rotavirus triple-layered 
particle. The spike proteins VP4 is colored in orange and the outermost VP7 layer in yellow. (C) 
A cutaway view of the rotavirus TLP showing the inner VP6 (blue) and VP2 (green) layers and 
the transcriptional enzymes (shown in red) anchored to the VP2 layer at the five-fold axes. (D) 
Schematic depiction of genome organization in rotavirus. The genome segments are represented 
as inverted conical spirals surrounding the transcription enzymes (shown as red balls) inside the 
VP2 layer in green. (E and F) Model from Cryo-EM reconstruction of transcribing DLPs. The 
endogenous transcription results in the simultaneous release of the transcribed mRNA from 
channels located at the five-fold vertex of the icosahedral DLP. Source: (246), with permission 
of the author. 
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Figure 3. Replication cycle of rotavirus. Source: (7), with permission of the publisher. 
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Abstract 
Rotavirus-associated diarrhea is a common enteric disease in piglets. Group A, B and C 
rotaviruses have been commonly implicated in US swine while group H was recognized recently. 
To date, isolates and genomic information of porcine rotavirus (PoRV) B and C are limited due 
to difficulty in virus isolation. As a result, laboratory tools specific for PoRV B and C are sparse. 
The study objective was producing monoclonal antibodies (MAbs) against PoRV A, B and C. To 
that goal, the whole VP6 gene of rotavirus of each group was cloned from feces positive for each 
group and expressed in a baculovirus system using Bac-to-Bac cloning and expression kit. The 
recombinant proteins, purified in native conditions, were then used to immunize mice. An 
ELISA using recombinant VP6 protein of PoRV A, B or C and IFA test using Sf9 cells 
expressing VP6 protein of PoRV A, B or C were used to screen hybridomas. The resultant MAbs 
were verified for their protein specificity by Western immunoblot and isotyped. Based on the 
evaluation, MAb 10A11, 10B1 and 11H3, all of which were of IgG, were selected for PoRV A, 
B and C, respectively. Of three  MAb10A11 and 11H3 were successfully used in 
immunohistochemical staining to detect PoRV A and C, respectively, in formalin-fixed paraffin-
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embedded tissues collected from experimentally infected pigs. In conclusion, murine MAbs 
specific for VP6 protein of PoRV A, B and C were successfully produced, which can be useful 
reagents for research of PoRV A, B and C laboratory diagnosis of PoRV A and C. 
I. Introduction 
 
Porcine rotavirus, which belongs to the genus Rotavirus in the family Reoviridae, is an 
important swine viral enteric pathogen causing diarrhea in piglets. Rotavirus genome has 11 
segments of double-stranded RNA, approximately 18.5 kb in size, which encode 6 non-structure 
proteins (NSP1, 2, 3, 4, 5, 6) and 6 structure proteins (VP1, 2, 3, 4, 6, 7). The virions have three 
layers making a double capsid structure. The outermost layer comprises of VP4 (86 kDa) and 
VP7 (37 kDa) proteins which are necessary for virus entry and are important in protective 
immunity as these proteins contain neutralization epitopes (1, 2). The middle layer is the VP6 
protein (44kDa) which is the most abundant and conserved structural protein and highly 
immunogenic. The core comprises scaffolding VP2 proteins, RNA-dependent-RNA polymerase 
VP1, and the guanylyltransferase and methylase VP3 (3). 
Based on the antigenicity and sequence of VP6 protein/gene, rotaviruses are divided into 
10 groups, A through J (4,5,6,7). Of these, group A, B, and C rotaviruses have demonstrated 
their ability to cause disease in pigs (8,9). The nucleic acid of group H rotavirus has been 
detected by next-generation sequencing in feces from a diarrheic pig without any other 
rotaviruses; however, Koch’s postulates have not been fulfilled yet. Although diagnostic 
laboratory data suggest that porcine rotavirus (PoRV) C has been detected more commonly in 
neonatal and suckling piglets (<21days of age) compared to PoRV A and B (10), most of the 
studies of porcine rotavirus  have been done on PoRV A. 
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Because genomic sequences of PoRV B and C have been sparse, laboratory tools specific 
for PoRV B and C are limited except PCRs (11,12,10). Disadvantages of PCR are: a) inability to 
distinguish the infectious virus from inactive form; b) inability to detect agents that have 
mutation(s) in the primer binding sites; and c) negative impact on its performance by inhibitors 
in feces (13). Antigen or antibody-based methods, such as enzyme- linked immunosorbent assay 
(ELISA), immunohistochemistry (IHC), and immunofluorescence microscopy, could be good 
alternatives and/or supplements. Thus, the goal of this study was to produce monoclonal 
antibodies (MAbs) specific for PoRV A, B, and C which can be used in diagnostics and research. 
II. Materials and Methods 
2.1 Study design 
The VP6 gene of each of PoRV A (ISU2010035768), B (ISU2011025309A), and C 
(ISU2010025060P) was cloned and expressed in a baculovirus system. The recombinant VP6 
proteins were then purified and used to immunize mice. Two weeks after the last immunization, 
seraa were collected from the mice and tested by ELISA to confirm the immune response to the 
given antigen in each mouse. Mice with the highest optical density (OD) value to be euthanized 
for murine spleens, and the splenocytes were subsequently collected and used for cell fusions. 
After 1 to 2 weeks, all hybridoma supernatants were screened by ELISA using each of the 
recombinant VP6 proteins as antigen, and the positive ones were further tested by indirect 
fluorescent antibody (IFA) assay. Monoclonal antibodies positive by both ELISA and IFA test 
were then selected for further evaluation. The specificity of the selected MAbs for respective 
VP6 protein was confirmed by Western immunoblot (WIB). Isotypes of the MAbs were 
determined. VP6-specific MAbs of IgG isotype with the strongest reactivity on ELISA, IFA 
assay and WIB for each rotavirus group were then selected and evaluated for their utility in 
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immunohistochemical staining of formalin-fixed paraffin-embedded tissues for specific detection 
of PoRV A, B or C. 
2.2 Sequencing VP6 of porcine rotavirus B 
Since VP6 sequences of group B porcine rotaviruses were not available in public 
domains at the time of starting the study, the PoRVB strain employed for the study was 
sequenced by using full-length amplification of cDNAs (FLAC) method (14).  
Fecal samples containing PoRV B (ISU2011025309A) from previous studied (15) were 
used to clone PoRV B VP6 gene. PoRV B RNA was extracted from the fecal samples using 
Trizol (Thermo Fisher Scientific, Walham, Massachusetts) by following manufacturer’s 
instruction. The single-stranded viral RNA was precipitated by mixing with 4M LiCl (Sigma-
Aldrich, St. Louis, Missouri) at the 1:1 ratio and incubating for 16 hours at 4°C followed by a 
centrifugation at 16000 x g for 30 minutes. The double-stranded (ds) RNA from the supernatant 
was purified by using MinElute gel extraction kit (Qiagen, Valencia, California) (16). The ds 
RNA was electrophoresed on  a 10% polyacrylamide gel in a large gel format for 16-20 hours at 
100 volts (V) (17). The gel then was stained with 1:10000 diluted SYBR Gold (Thermo Fisher 
Scientific) for 30 minutes. The individual bands visualized under ultraviolet light were cut out 
and applied in SnakeSkinR tubing, 10kDa (Thermo Fisher Scientific) for electrophoresis at 150V 
for 30 minutes to collect RNA fragment from the gel. The RNAs were then precipitated by 
ethanol.  
The  full-length amplification of VP6 was done based on the protocol described 
somewhere (18). Briefly, 200ng of rotavirus RNA was ligated to 250ng PC3-T7 loop primer (5’- 
p–GGATCCCGGGAATTCGGTAATACGACTCACTATATTTTTATAGTGAGTCGTATTA–
OH-3’) (16) using T4 RNA ligase (Promega, Madison, Wisconsin) supplemented with 10% 
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DMSO (Sigma-Aldrich) and 20% PEG (Sigma-Aldrich) at 37°C for overnight. Then, the primer 
ligated RNAs were purified by using MinElute gel extraction kit and denatured at 98°C for 2 
minutes with 1M betaine (Sigma-Aldrich) and 2.5% (v/v) DMSO, then chilled on ice for 5 
minutes to prevent the RNA going back to the original conformation. The cDNAs were 
synthesized using Supercript™ III first-strand synthesis system for RT-PCR (Thermo Fisher 
Scientific) by following manufacturer’s instructions. The products were incubated with 0.1M 
NaOH at 70°C for 20 minutes to degrade RNA and then with 0.1M Tris-HCl (pH 7.5) and 0.1M 
HCl at 68°C for 1 hour and 65°C for 2 hours to neutralize NaOH. 
The synthesized cDNAs were purified by using MinElute gel extraction kit by following 
manufacturer’s instructions and then used for PCR with Accuprime™ Taq polymerase (Thermo 
Fisher Scientific) and 1.25µM PC2 primer (18). The running condition was 72°C for 2 minutes, 
94°C for 2 minutes (initial dissociation), 35 cycles of 94°C for 25 seconds (increasing 1second 
per cycles), 65°C for 30 second and 68°C for 5 minutes, and final extension at 68°C for 10 
minutes. PCR products were analyzed by 1% agarose gel electrophoresis and purified by 
MinElute gel extraction kit, then subjected for TA cloning using pGEM®-T vector (Promega). 
The plasmids were sequenced with M13 primers to determine the cloned sequence. 
2.3 Cloning and expression of PoRV A, B, and C VP6 genes 
The cloning and expression of VP6 genes of PoRV A, B, and C were done with a Bac-to-
Bac® cloning and expression kit (Invitrogen, A11098) as per the manufacturer’s instruction. 
Briefly, the full-length VP6 gene of each of PoRV A, B, and C and the corresponding coding 
regions were amplified by a PCR method using primers shown in Table 1, which were designed 
by PrimerSelect (DNASTAR, Madison, WI), and AccuPrime™ Pfx polymerase (Thermo Fisher 
Scientific, Waltham, MA). Each PCR product then was cloned in a pFastBac™ TOPO® vector 
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(Thermo Fisher Scientific). Next, the plasmids with VP6 gene of PoRV A, B or C, which were 
intact and had the correct direction, were transformed to MAX Efficiency™ DH10Bac™ 
competent E. coli cells (Thermo Fisher Scientific) by following manufacturer’s recommended 
procedure. Subsequently, the bacmids were extracted using PureLink® HiPure DNA isolation kit 
(Thermo Fisher Scientific) by following the manufacturer’s user manual. The bacmids, 500ng/µl 
in TE buffer (10mM Tris, 1mM EDTA, pH8) were transfected into Sf9 cells (Thermo Fisher 
Scientific) using Cellfectin® (Thermo Fisher Scientific) by following manufacturer’s 
recommended procedure. After 96-hour incubation, the media containing PoRV A, B or C VP6 
recombinant baculovirus were collected and were designated passage 1. After being propagated 
to passage 2 and tested for the titers by plaque assay, each of the recombinant baculoviruses was 
used to infect Sf9 cells prepared in Sf-900 II SFM media (Thermo Fisher Scientific) at 10 
multiplicity of infection (moi) and the inoculated Sf9 cells were incubated for 48 hours. The cell 
supernatants were collected for protein purification. 
2.4 Purification of expressed recombinant VP6 proteins 
The recombinant VP6 proteins of PoRV A, B, and C were purified under native 
conditions using the Ni-NTA Purification System (Thermo Fisher Scientific) in which urea was 
not used in attempt to preserve the native structure of VP6 protein. In brief, VP6 protein 
expressing Sf9 cells in two 192cm2 cell culture flasks (Thermo Fisher Scientific) for each 
rotavirus group were lysed in 8ml of 1X native purification buffer (50mM NaH2PO4 and 0.5M 
NaCl; pH 8.0) added with leupeptin (Sigma Aldrich, St. Louis, MO) at the rate of 0.5 μg/ml by 
freeze-and-thawing three times and then passed through 18-gauge needles. The lysates were 
centrifuged at 8000 x g for 30 minutes for clarification. The resulting supernatants were poured 
into Ni-NTA gel columns and retained for one hour with the columns being rotated. Then the 
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gels were washed four times by flowing the native purification buffer containing 20 mM 
imidazole (pH 8.0) through the columns. Finally, the proteins were eluted by flowing 8ml of the 
native buffer containing 250 mM imidazole (pH 8.0) through each column. Imidazole was then 
removed from each protein preparation by centrifuging each eluate in Amicon® Ultra-15, 30 kDa 
(Millipore, Billerica, MA) at 4000 x g for 30 minutes. 
 For the VP6 protein of PoRV B, mice screening results demonstrated that the 6X His tag 
had to be removed for immunization purpose; hence it was cut using AcTEV™ Protease 
(Thermo Fisher Scientific) and removed from the final VP6 protein as suggested in the 
manufacturer’s user manual.  
2.5 Mouse immunization and cell fusion 
All of pertinent procedures were done at the Hybridoma Facility of Iowa State University. 
Three specific-pathogen-free 4- to 6-week old BALB/c mice each were immunized twice with a 
2-week interval by subcutaneous injection of each of the VP6 proteins (20 µg per mouse) mixed 
with incomplete Freund’s adjuvants (MP Biomedicals, Santa Ana, CA) at the 1:1 ratio. Sera 
were collected from all immunized mice via mandibular vein 2 weeks after the second 
immunization and were evaluated by ELISA as described below. Mice were euthanized for 
sterile splenectomy at 5 days after the third time injection without any adjuvant via 
intraperitoneal route. Splenocytes were aseptically harvested from each collected murine spleen 
for cell fusion. Sp2/O-Ag14 murine myeloma cells (ATCC, Manassas, VA ) were prepared as 
fusion partner at the rate of 4 x 107 and washed three times by Dulbecco’s Modified Eagle’s 
Medium (Sigma) without fetal bovine serum. The Sp2/O cells were pelleted by centrifugation 
and mixed with pelleted mouse splenocytes at the 1:1 ratio. Fusion of two cell types was 
enforced in the presence 1ml of polyethylene glycol (Roche). Next, 10ml of warm DMEM was 
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added dropwise and after 10-minute incubation, the mixture was centrifuged at 100 x g for 10 
minutes. The resulting pellet was suspended in the 75ml DMEM containing 1X of HAT (100µM 
hypoxanthine, 0.4µM aminopterin, 16µM thymidine; Sigma) supplemented with 10% horse 
serum (Atlanta Biologicals, Flowery Branch, GA) and antibiotics containing 100 units/ml 
penicillin and100µg/ml streptomycin (Sigma-Aldrich), and dispensed into cell-culture grade, 
flat-bottomed 96-well polystyrene plates and incubated at 37°C for 1 to 2 weeks. When 90-100% 
confluency of the cells was made, the supernatants were collected for screening by ELISA. The 
selected hybridomas were transferred to 24-well plates for expansion. Subsequently, when the 
cells reached full confluence in the wells, the supernatants were collected for screening by 
ELISA for the second time. The selected hybridomas were serially scaled up to larger cell 
cultureware (i.e., 25cm2 flasks and then 75cm2 flasks) and eventually stored frozen in the liquid 
nitrogen.  
2.6 ELISA  
To prepare antigens, MaxiSorp® flat-bottom 96-well plates (Nunc, 442404) were coated 
with each VP6 (50ng/well) in a commercially available phosphate buffer (pH 7.2) containing 
0.1M sodium phosphate and 0.15M sodium chloride (Thermo Fisher Scientific) overnight at 4°C. 
The plates then were washed five times with a wash buffer (phosphate-buffered saline with 0.1% 
Tween 20, pH7.2), blocked with 300µl/well of 1% bovine serum albumin (Jackson 
ImmunoResearch Laboratories, West Grove, PA) for 2 hours at ambient temperature and dried 
for 2 hours at 37°C. The primary antibodies (i.e., mouse serums or hybridoma supernatant; 
50µl/well) were added to the plates and incubated for 30 minutes at 37°C in a humidified 
chamber. After washing three times with the wash buffer, the plates were incubated with anti-
mouse IgG secondary antibody labeled with peroxidase (Seracare, Milford, MA) for 30 minutes 
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at 37°C. After three times washing, the plates were incubated with a TMB substrate (100µl/well) 
(Seracare, Milford, MA) at room temperature (20-22°C) in the dark. Colorimetric reactions were 
stopped by adding 0.1M H2SO4 stop solution (100µl/well). The plates were then read by a 
microplate ELISA reader and OD of each hybridoma supernatant was determined at 450nm 
wavelength. The hybridomas with OD>0.5 were considered positive for the target VP6 and were 
selected for further testing. 
2.7 Indirect fluorescent antibody assay 
To prepare antigens, Sf9 cells were seeded in 96-well cell culture plates at the rate of 
3x105cells/well. One hour later, the cells were inoculated with recombinant baculovirus 
containing VP6 gene of PoRV A, B, or C at the rate of 1 moi. At 48 hours after infection, the 
cells were fixed by 80% cold acetone aqueous solution for 15 minutes at -20°C.  
Hybridoma supernatants which were positive for the respective VP6 by ELISA were 
applied to each well in the plates (50µl/well). The plates were incubated at 37°C for 1 hour in a 
humidified chamber. After washing three times with phosphate-buffered saline (PBS, pH7.2), 
optimally diluted goat anti-mouse IgM+IgA+IgM (H+L) polyclonal antibody conjugated with 
fluorescein isothiocyanate (Seracare, Milford, MA) was dispensed into each plate (100 µl/well) 
and incubated for 30 minutes at 37°C under the humidified condition. The plates were then 
washed three times with PBS and examined under a fluorescent microscope for specific 
fluorescence. 
 The finally selected MAbs specific for PoRV A and C VP6 were further evaluated on 
MA-104 and IPEC-1 infected with PoRV A and PoRV C, respectively by IFA test in the 
identical manner described above.  
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2.8 Western immunoblot (WIB) 
Western immunoblotting was performed to confirm the production of the VP6 proteins as 
well as the specific recognition of MAbs for the VP6 proteins (19). The purified 6xHis-VP6 
proteins were processed through SDS-PAGE and transferred to nitrocellulose (NC) membranes 
(Bio-Rad Laboratories, Hercules, CA). Each membrane was blocked with 20ml of 5% (W/V) 
non-fat dried milk at room temperature for 1 hour at room temperature. For confirming the 
production of the VP6, the membranes were incubated with 10ml of 1:10000 diluted 6X His tag 
monoclonal antibody (Thermo Fisher Scientific) for 1hour. While for the specific recognition of 
MAbs for the VP6 proteins, the membranes were incubated with 10ml of hybridoma cell culture 
supernatant containing MAb that was positive for PoRV A, B or C by ELISA and IFA for 1 hour 
at room temperature. After washing three times with Tris-buffered saline (pH 7.4) with 0.5% 
Tween 20 (TBST), the membranes were incubated anti-mouse IgG labeled with peroxidase 
(Seracare, Milford, MA) for 1 hour at room temperature. Finally, each membrane was washed 
three times with TBST and immersed in 5 ml of TMB substrate (Seracare). The colorimetric 
reactions were stopped by washing two times with distilled water.   
2.9 Isotyping of monoclonal antibodies 
Monoclonal antibodies in all selected hybridoma supernatants were isotyped using 
IsoStrip™ Mouse Monoclonal Antibody Isotyping Kit (Roche, Basel, Switzerland) by following 
the manufacturer’s instructions. 
2.10 Immunohistochemistry (IHC) 
To evaluate the diagnostic utility of MAbs produced, the selected MAbs were applied to 
immunohistochemical staining of formalin-fixed paraffin-embedded intestinal tissues for 
rotaviruses. While anti-PoRV A VP6 MAb was used in forms of hybridoma cell culture 
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supernatants, MAbs for VP6 of PoRV B and C were purified by Melon™ gel Monoclonal IgG 
purification kit (Thermo Fisher Scientific, 45214) to reduce the background issue and increase 
the concentration before being used in IHC based on preliminary testing results. 
Intestinal tissues used to evaluate the MAbs were collected from piglets experimentally 
infected with PoRV A, B or C in a previous study conducted in our laboratory (15) . After being 
formalin-fixed and paraffin embedded, the tissues were cut into 4-μm sections and fixed into 
glass slides at 55°C for 30 minutes. Subsequently, the IHC processes were carried out by Leica 
Bond III autostainer (Leica Biosystems, Buffalo Grove, IL) following the standard protocol from 
Iowa State University Veterinary Diagnostic Laboratory (SOP #9.369).  
III. Results 
3.1 Sequence analysis of PoRV B 2011025309A 
Sequencing demonstrated that VP6 gene (full-length) of PoRV B (ISU2011025309A) is 
1269 nucleotides long and has one open reading frame of 1176 nucleotides which encodes 391 
amino acids. This sequence has the same length as VP6 genes of other porcine rotaviruses.  
Sequence comparison showed 66-90% similarity with VP6 genes of other group B porcine 
rotaviruses which became available in the public domain during the study and 68-78% similarity 
with rotavirus B in other species (human, bovine).  
3.2 Protein expression  
VP6 protein of PoRV A, B or C was successfully expressed from each of the 3 
constructed recombinant baculoviruses in Sf9 cells although the level of protein expression from 
each construct differed. All 3 purified proteins were approximately 43-44 kDa in size on 12% 
SDS-PAGE followed by Western immunoblot using anti-6X His tag antibody as illustrated in 
Figure 1.  
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3.3 Screening hybridoma supernatant by ELISA 
Two weeks after fusion, supernatants of hybridomas in 96 well plates were collected and 
screened for production of antibody against VP6 proteins of PoRV A, B and C by ELISA. 
Twenty-positive hybridoma clones were selected and subcultured to 24-well plates for expansion. 
After 2 weeks, supernatants of those hybridomas were screened again by ELISA to make sure 
that the hybridomas were stable in antibody secretion. Finally, two hybridoma clones each for 
PoRV A, B and C VP6 which had the highest OD were selected and designated 10A11 (group A), 
12C10 (group A), 10B1 (group B), 10F7 (group B), 10B5 (group C), and 11H3 (group C). 
3.4 Characterization of monoclonal antibodies 
The six selected hybridoma clones were shown to produce antibody specific for the 
intended target, i.e., VP6 protein of PoRV A, B or C without any cross reactivity when tested by 
IFA assay against Sf9 cells inoculated with the recombinant baculovirus containing the 
respective VP6 gene as illustrated in Figure 2. Moreover, the MAb 10A11 and 11H3 specifically 
recognized PoRV A and C, respectively, which were propagated in MA-104 and IPEC-1 cells, 
respectively as showed in Figure 3. 
 All six MAbs except one (10F7) were of IgG isotype (Table 2). On WIB, all the MAbs 
specifically recognized the corresponding recombinant VP6 proteins of 43-44 kDa in size as 
shown in Figure 4. Furthermore, the MAb 10B1 reacted with native VP6 protein from a lysate of 
virus material prepared from PoRV B-positive feces (unshown data). 
3.5 Application of monoclonal antibodies in IHC for porcine rotaviruses 
Anti-PoRV A VP6 MAb 10A11, in the form of the hybridoma culture supernatant, could 
specifically detect the presence of PoRV A in small intestinal tissues collected from neonatal 
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piglets experimentally infected with PoRV A (Figure 5 left panel). The specific reactivity of the 
MAb for PoRV A remained up to 1:10000 dilution. 
Initial IHC attempts with anti-PoRV C VP6 MAb 11H3 in the form of the hybridoma 
culture supernatant was unsuccessful. After purification and concentration, the MAb was able to 
specifically recognize the presence of PoRV C in intestinal tissues collected from experimentally 
infected pigs as shown in Figure 5 (right panel). 
In contrast to the MAbs specific for VP6 of PoRV A and C, the anti-PoRV B VP6 MAb 
10B1 and 10F7 did not work in IHC to detect the presence of PoRV B in intestinal tissues from 
experimentally infected pigs despite of applying purification/concentration of hybridoma 
supernatants and trying different protocols for antigen retrieving methods (enzyme versus heat), 
different buffers for heat retrieving method, and different running temperature conditions.  
IV. Discussion 
 
The VP6 protein of rotavirus is an abundant and highly immunogenic rotaviral protein 
among viral structural proteins and is most commonly used as target for rotavirus diagnostics 
(20). It has also been used as the basis for (sero)grouping of rotavirus (3). That was the rational 
for developing VP6-specific monoclonal antibodies for each of porcine rotavirus A, B, and C. 
The development of MAb against VP6 of PoRV B had a couple of challenges. First, there 
was no VP6 sequence for PoRV B available in public domains when this study was initiated. The 
sequence was achieved by using full-length amplification of cDNA technique, which was 
developed by (14), to sequence genomes of double-stranded RNA viruses. While this method 
itself should have been straightforward and easily reproducible, a problem was encountered in 
this study because the protocol had to be used on the RNA of PoRV B extracted from feces. 
Some RNA fragments, such as NSP3, NSP1, and VP1, seemed to be more preferably ligated 
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with PC3-T7 loop primers than the rest including VP6; hence, VP6 sequences could not be 
achieved. This problem was resolved with separating the RNA fragments by PAGE, excising 
individual bands from the gel, and eluting each RNA fragment by electrophoresis in a dialysis 
tube. The eluted RNAs were then precipitated and used for ligation. This method is newly 
attempted for the first time in this study and should be applicable in sequencing other viruses 
with ds RNA genomes. Second, attempts to get a hybridoma cell clone that secret MAbs specific 
to VP6 of PoRV B were unsuccessful while the clones positive to 6X His tag were dominant. 
The reason could be the 6X His tag interfere with biological activity of protein (21). This 
problem was resolved by cleaving of 6X His tag from the recombinant PoRV VP6 protein before 
immunizing mice with the protein. 
Unfortunately, none of the MAbs against PoRV B worked in IHC although they were 
functional in the other tests such as ELISA, IFA assay, and WIB. Thus, the development of 
PoRV B MAb that can be used in IHC is remained to be further explored. Moreover, it should be 
noted that the monoclonal antibodies for PoRV A and C produced in this study were not 
evaluated on other strains within each serogroup using a large numbers of clinical cases. 
Therefore, it remains to be assessed how broadly each MAb can recognize various rotavirus 
strains circulating in swine herds, knowing a high degree of genetic variability among rotaviruses 
within each group although VP6 is known to be antigenically conserved for each group.  
No MAb against PoRV C is commercially available although PoRV C appears to be 
common in pre-weaning piglets compared to PoRV A or B based on results of PCR-based 
assessment at diagnostic laboratories (10). In this sense, MAb 11H3 would be a valuable reagent 
for diagnostic and research purpose. Although PCR-based assays are being used most commonly 
to detect PoRV in fecal materials from diarrheic pigs at many veterinary diagnostic laboratories, 
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PCR testing has limitations: a) the diagnostic sensitivity of PCR can be interfered by inhibitors 
commonly found in feces or the mutations commonly found in RNA viruses; b) PCR cannot 
differentiate infectious viruses from inactivate ones; and c) it is not uncommon to detect more 
than one rotavirus groups when testing feces. Thus, the accuracy of rotavirus diagnostic related 
to the causative role of PoRV in enteric disease can be enhanced by employing an assay 
detecting virus in tissues with lesions, such as cryosection fluorescent antibody test and IHC 
when monospecific antibodies for the virus are available. Since rotaviruses are ubiquitous in 
swine herds, detecting rotavirus antibody may have little diagnostic value. However, serology 
assays such as IFA assay and indirect or blocking ELISA which can assess isotype of the 
antibodies might still be valuable in identify the status of the rotavirus infection/vaccination in 
swine populations. Thus, the recombinant VP6 proteins and MAbs achieved in this study can be 
the crucial reagents for developing assays for rotavirus antigen and antibodies, which are 
warranted to be further studied in the future. 
In conclusion, recombinant VP6 proteins of PoRV A, B, and C and murine monoclonal 
antibodies (IgG isotype) specific for VP6 proteins of PoRV A, B, and C were successfully 
developed, which can be used for research and diagnostic purposes. In particular, the availability 
of the antibodies 10A11 and 11H3, which are specific to PoRV group A and C, respectively and 
can be used in IHC, may be useful to study the pathogenesis of rotaviruses in pigs.  
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Table 
Table1. Primers used for amplifying full length and coding regions of VP6 of porcine rotavirus A, B, and C 
 
Primers Forward Reverse References 
VP6- A GGCTTTTAAACGAAGTCTTC GGTCACATCCTCTCACTA (22) 
VP6- B GGTATTAATTAGTCCAATCAGGGTTGC CTATTTTTTTCATCCTCTCGAAGCA This study 
VP6- C GCATTTAAAATCTCATTCACA AGCCACATAGTTCACATTTC (23) 
VP6- A coding ATGGAGGTTCTGTACTCATTGTCA CTTAATCAACATGCTTCTAATGGAAG This study 
VP6- B coding ATGGATCTGATCGAAACAGTGAAC GATCTTAGCAGCGAACGAAGC This study 
VP6- C coding ATGGACGTGCTATTTTCCATTG CATCACCATTCTCTTCACGGA This study 
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Table 2. Characteristics of anti-porcine rotavirus (PoRV) VP6 monoclonal antibodies produced 
 
Hybridoma 
ID 
Isotype Serogroup 
specificity 
Immunofluorescence test on Immunohistochemistry on small intestine 
from pigs inoculated with 
MA-104 cell infected 
with PoRV A 
IPEC-1 cell infected 
with PoRV C 
PoRV A PoRV B PoRV C 
10A11 IgG PoRV A + ̶ + ̶ ̶ 
12C10 IgG PoRV A N/D* N/D N/D N/D N/D 
10B1 IgG PoRV B N/A§ N/A ̶ ̶ ̶ 
10F7 IgM PoRV B N/A N/A ̶ ̶ ̶ 
10B5 IgG PoRV C N/D N/D N/D N/D N/D 
11H3 IgG PoRV C ̶ + ̶ ̶ + 
 
*N/D = not determined 
§N/A = not applicable 
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Figure 
 
 
Figure 1. Confirmation of VP6 protein expression in Sf9 cells inoculated with recombinant 
baculovirus constructed to contain VP6 gene of porcine rotavirus A (lane A), B (lane B) and C 
(lane 3) by Western immunoblot using anti-6XHis tag monoclonal antibody 
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Figure 2.  Specific reactivity of monoclonal antibody 10A11, 10B1 and 11F3 with recombinant 
VP6 protein expressed in Sf9 cells infected with a recombinant baculovirus constructed to 
contain VP6 of porcine rotavirus A (panel A), B (panel B), or C (panel C) or wild type (D), 
respectively, as determined by indirect fluorescent antibody assay 
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Figure 3. Specific reactivity of anti-VP6 monoclonal antibodies 10A11 and 11F3 with porcine 
rotavirus A (left panel) and C (right panel) propagated in MA-104 and IPEC-1 cells, respectively, 
as determined by indirect fluorescent antibody assay 
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Figure 4. Specific recognition of recombinant VP6 protein of porcine rotavirus A, B and C by 
monoclonal antibody 10A11 (A), 10B1 (B) and 11F3 (C), respectively, as determined by 
Western immunoblot technique 
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Figure 5. Immunohistochemical staining of enterocytes infected with porcine rotavirus A (left 
panel) and C (right panel) in small intestine by VP6-specific monoclonal antibody 10A11 and 
11F3, respectively 
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Abstract 
 
 Rotavirus, which has been classified in ten groups (A to J), is an important cause of 
diarrheal disease in human and animals. In pigs, rotavirus A, B and C are common groups 
identified and cause enteric disease mostly in young pigs. Historically porcine rotavirus (PoRV) 
A has been the main cause of post-weaning diarrhea. Recently neonatal diarrhea associated with 
PoRV C infection has been increasingly diagnosed while PoRV B has been identified in all ages, 
suggesting that rotavirus groups vary in the pathogenicity in neonatal pigs. The following study 
was conducted to compare the pathogenicity of PoRV A, B, and C individually or in 
combinations in naïve newborn piglets. Forty-eight one-day-old cesarean-derived colostrum-
deprived (CDCD) pigs were divided into eight treatment groups. Pigs in each group were 
challenged with PoRV that belong to individual group A, B, C or all combinations of group A, B 
and C. Clinical signs were recorded every 12 hours post inoculation (hpi). Rectal swabs were 
obtained before inoculation and then every 12 hpi. Half of the pigs in each group were 
euthanized at 24 hpi and the rest were at 72 hpi. Intestinal contents were collected at necropsy. 
The swabs and contents were tested by RT-PCR assay for virus shedding. Multiple parts of the 
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intestine (i.e., duodenum, jejunum and ileum) were collected for histopathology. All rotaviruses 
used caused diarrheal disease in neonatal piglets regardless of their groups. There was no 
remarkable difference in the severity of diarrhea caused by rotavirus A, B, and C or 
combinations although the onset of PoRV B and C shedding was earlier than PoRV A. All the 
rotavirus inocula were able to cause atrophic enteritis. Although the lesion caused by PoRV A 
was more prevalent in mid to distal jejunum, the viral antigen was found throughout the small 
intestine. Porcine rotavirus B and C caused diffuse villous atrophic change throughout the small 
intestine which was corresponded with the positive viral nucleic acid and antigen detection, 
respectively.  In conclusion, all rotavirus groups are equally pathogenic to immunologically 
naïve neonates but may vary in their replication patterns in intestine. 
I. Introduction 
 
Porcine rotavirus, a non-enveloped and icosahedral RNA virus, belongs to the genus 
Rotavirus in the family Reoviridae. The rotavirus genome has 11 double-stranded RNA 
segments with varying size which encode 6 nonstructural proteins (NSP1, 2, 3, 4, 5, and 6) and 6 
structural proteins (VP1, 2, 3, 4, 6, and 7). The virion has three protein layers making double 
capsid structure. The most outer layer comprises of VP4 and VP7 which are necessary for virus 
entry. The middle layer is made by VP6, a most abundant structure protein. The core comprises 
scaffolding VP2 proteins, RNA-dependent-RNA polymerase VP1, and the guanylyltransferase 
and methylase VP3 (1). 
  Rotaviruses are divided into 10 groups (A-J) base on antigenicity and sequence of VP6 
(2-5). Of these, rotavirus A, B, C, E, and H have been implicated in enteric disease of pigs (6, 7). 
Porcine rotavirus (PoRV) A, B, C, and H have been found in US swine populations (7, 8). 
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All rotaviruses are known to primarily target mature, non-dividing enterocytes on the tips 
of villi in the small intestine (1). The viral replication in enterocytes results in the cell lysis and 
consequently causes villous blunting and atrophy. The age of pigs (9) and rotavirus strains (10) 
have been attributed for different degrees of villous atrophy severity. Clinically, rotavirus 
infection in pigs is manifested by diarrhea and dehydration (11), which causes a moderate 
economic loss in the swine industry (12). Rotavirus-associated diarrhea is attributed to 
malabsorption as well as increased secretion due to enterocyte destructions, viral enterotoxin 
(NSP4) and stimulation of the enteric nervous system (1). 
Based on rotavirus PCR test results on case submissions to veterinary diagnostic 
laboratories, PoRV A has been most prevalent in 21- to 42-day-old pigs (i.e., post-weaning), 
whereas PoRV B have been found equally in all ages although more than 50% of rotavirus B 
positives were in pigs of 3 weeks of age or older, and PoRV C have been frequently found in 
neonates and suckling piglets (i.e., pre-weaning). From the observed difference in age 
distribution of rotavirus groups, it was hypothesized that PoRV A, B and C may differ in their 
ability to cause disease in neonatal pigs. The following comparative pathogenicity study was 
conducted to address it. The specific objective of the study was to compare the clinical signs, 
viral shedding, and intestinal destruction in pigs infected with PoRV A, B, and C singularly and 
in all combinations including co-infecting a subset of pigs with all three groups simultaneously. 
II. Materials and Methods 
 2.1 Animals 
Pregnant cross-bred sows were purchased from a commercial breeding herd and 
delivered to Iowa State University (ISU) Livestock Infectious Disease Isolation Facility (LIDIF) 
approximately one week prior to the expected farrowing date. On day 113 of gestation, caesarian 
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section surgeries were performed on the sows for piglet derivation. Neonatal piglets were 
separated from dams immediately upon birth and did not receive colostrum. Therefore, 
caesarian-derived and colostrum-deprived (CDCD) neonatal piglets were used in this study. All 
CDCD piglets included in this study were triaged at birth with navels clamped, cut, and sprayed 
with gentile iodine. Piglets received an iron and antibiotic injection (Excede®, Pfizer) per 
labeled directions. 
2.2 Study design 
Piglets were randomly divided into eight treatment groups with six piglets each. Piglets 
were inoculated with virus-free media (negative control) or with PoRV A, B, or C singularly and 
all possible combinations via orogastric gavage. Table 1 summarizes the study design. Study 
termination points were 24 and 72 hours post inoculation (hpi); half of the pigs in each group 
were euthanized at 24 hpi and the remaining piglets at 72 hpi. 
2.3 Housing and care 
All animals were housed in the ISU LIDIF. Piglets were individually housed in new 
plastic totes which were commercially purchased and each treatment group was kept in a 
separate temperature controlled room with HEPA filtration. Piglets were fed milk replacer 
(Esbilac; Pet-Ag, Hampshire, IL) three times a day (7 am, 12 pm, and 7 pm). All feedings were 
done by oral-gastric lavage using an 8-gauge French catheter. Different group of caretakers were 
assigned to each group. Strict shower-in/shower-out was practiced to prevent cross 
contamination between treatments. 
2.4 Inoculum and inoculation 
Rotaviruses used in this experiment were obtained from clinical cases during diagnostic 
investigation. The PoRV A isolate (ISU2010035768) were made and propagated in MA-104 
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cells using 1µg/ml trypsin in infection media as previously described (13). The titer of PoRV A 
was 106 plaque-forming units (PFU)/ml. PoRV B (ISU2011025309A) and C (ISU2010025060P) 
were prepared from feces through a series of purification by laboratory techniques and 
amplification in CDCD piglets in a similar manner previously described (14, 15).   
Each rotavirus inoculum was then adjusted to contain approximately 1,000 PFU/ml 
equivalent. For that purpose, all rotavirus materials were serially diluted and tested by gel-based 
PCRs as previously described (16, 17). The rotavirus B and C were PCR-negative after 1:1000 
dilutions while the rotavirus A were PCR-negative at 1:1000000 dilution. The rotavirus A was 
then diluted 1:1000 in cell culture media to match its virus amount up with the virus amount in 
the rotavirus B and C inocula. The gel-based PCR was also used to confirm specificity of each 
inoculum. The amount of rotavirus RNA in the rotavirus A and C inocula was assessed by a 
quantitative real-time RT-PCR (ISUVDL-9.3284) and was confirmed to be similar.  
Piglets were orogastrically inoculated with virus(es) as shown in Table 1 approximately 4 
hrs post-surgery using an 8-gauge French catheter. Singularly infected groups (groups 2, 3, & 4) 
received 3 mL of inoculum orally. Dual infected groups (groups 5, 6, & 7) received 1.5 mL of 
each group and group 8 (triple infection) received 1 mL of each group. In this way, all pigs were 
given a similar total number of rotavirus genomic copies per pig. 
2.5 Sample collection 
Rectal swabs were taken from all piglets prior to inoculation and every 12 hours 
thereafter. At necropsy, rectal swabs, serum, colonic contents, and tissues of five segments of 
small intestine (i.e., duodenum, proximal jejunum, mid jejunum, distal jejunum, and ileum) were 
collected from all pigs. For consistency in sampling, the entire small intestine was extracted from 
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each pig, the mesentery cut away, and then folded back on itself several times (3 times). The 
same locations were cut from each pig as previously described (18). 
2.6 PCR 
Fecal swabs were tested by a quantitative real-time RT-PCR targeting VP6 gene of each 
rotavirus group with primers and probes listed in Table 2. The PCR for PoRV A and C was 
described previously (8). The PCR for PoRV B was developed specifically for the virus used in 
this study. The primers and probe were designed by Primer Express 3.0.1 (ThermoFisher 
Scientific, Waltham, MA) based on VP6 gene sequence of PoRV B which was obtained in a 
previously study (19). 
2.7 Histopathology 
After 48 h fixation in neutral buffered formalin, tissue sections were trimmed, processed, 
and embedded in paraffin. Four micron thick sections were cut and stained with hematoxylin and 
eosin by following the standard protocol (SOP #9.191) at Iowa State University Veterinary 
Diagnostic Laboratory (ISUVDL). Five perceived full length villi and crypts in each microscopic 
section of intestine were measured using a computerized image system (Olympus DP72 camera, 
cellSens Standard, Waltham, MA) (18). All assessment was done by one pathologist at a time 
and repeated by the second pathologist for reproducibility and confirmation. 
2.8 Immunohistochemistry (IHC)  
The IHC was done by following the standard protocol at ISUVDL (SOP #9.369). 
Formalin-fixed, paraffin-embedded intestinal tissues were cut and mounted on positively charged 
glass slides and dried at 60°C for 30 minutes, then loaded to the Leica Bond III autostainer 
(Leica Biosystems, Buffalo Grove, IL). The slides then were deparaffinized with xylene, three 
times, 5 minutes each and rehydrated with 100% alcohol, 95% alcohol, 70% alcohol, tap water, 
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and distilled water. Immunohistochemical staining was done using 10A11 and 11H3 murine 
monoclonal antibodies (MAbs) which were produced against PoRV A and C, respectively, in our 
laboratory previously (19). The antigen detection was semi-quantitatively estimated by a score 
system based on the following criteria: 0 = no signal, 1 = 1–20% of villous enterocytes within 
the section showing a positive signal, 2 = 21–50% of villous enterocytes showing a positive 
signal, and 3 = greater than 50% of villous enterocytes showing a positive signal. All slides were 
read by two designated pathologists, one at a time for consistency and reproducibility. 
2.9 In situ hybridization (ISH) 
An ISH-based test was used to detect RNA of PoRV B in intestinal tissues using an 
RNAscope® probe because a MAb-based IHC did not work for PoRV B. The probe specific for 
VP6 gene of the PoRV B strain used in the study was designed by Advanced Cell Diagnostics 
(Newark, CA, USA). The test was done by following manufacturer’s instructions. Briefly, the 
intestinal tissue embedded paraffin blocks were cut into 5µm sections. The ribbons were put in 
45°C water bath and mounted on Superfrost™ Plus slides (ThermoFisher Scientific, Waltham, 
MA). The slides were air-dried overnight and then were baked at 60°C for 1 hour. The 
deparaffinization was done by incubating the slides two times in xylene for 5 minutes each at 
room temperature (RT) and then washed two times in 100% ethanol for 1 minutes each at RT. 
The dried slides were incubated with RNAscope® Hydrogen Peroxide for 10 minutes at RT and 
washed three to five times with water. The slides were boiled in 1X retrieval buffer provided in 
the kit for 30 minutes and then washed immediately with water and finally with 100% ethanol. 
Next, the protease provided in the kit was applied to the slides and incubated for 30 minutes at 
40°C. Then the following steps were performed with two times washing for 2 minutes each in 
between. First, the probe was hybridized to RNA in the samples for 2 hours at 40°C. Next, Amp 
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1 to 6 was incubated with the sample in a step-by-step fashion for 30 minutes with Amp 1, 3, and 
5 and for 15 minutes with Amp 2, 4, and 6. The Amp1 to 4 were incubated at 40°C while Amp 5 
and 6 were incubated at RT. The hybridization was visualized by incubating with DAB for 10 
minutes at RT then washed with distilled water. The slides with were stained with 50% 
hematoxylin for 2 minutes and washed with distill water. Subsequently, the slides were 
dehydrated with 70% ethanol for 2 minutes, two times with 100% ethanol for 2 minutes each, 
and with xylenes for 5 minutes, at RT. The slides were dried at RT for 10 minutes and mounted 
with Cytoseal™ XYL (ThermoFisher Scientific) for 5 minutes. Finally, all slides were observed 
under  an optical microscope for scoring. The amount of PoRV B RNA was semi-quantitatively 
scored based on the following criteria: 0 = no signal, 1 = 1–20% of villous enterocytes within the 
section showing a positive signal, 2 = 21–50% of villous enterocytes showing a positive signal, 
and 3 = greater than 50% of villous enterocytes showing a positive signal.  All slides were read 
at the same time by the same person for consistency. 
2.10 Statistical analyses  
 Mean villous length by intestine sections and group were subjected to an analysis of 
variance (ANOVA) with mean comparison using an all pairs Tukey-Kramer adjacent. The same 
was done for crypt length. The viral shedding titers were compared using restricted maximum 
likelihood method. IHC and ISH scores were compared using a generalized linear mixed 
(GLIMMIX) by Statistical Analysis System (SAS) software version 9.3 (SAS Institute, Cary, 
NC). Significant differences were determined when p value was equal to or less than 0.05. 
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III. Results 
3.1 Clinical signs 
Diarrhea was not observed in any of the negative control pigs during the 74-hour study 
period after inoculation. In contrast, 50% and 100% of pigs in all of the virus-inoculated groups 
became diarrheic at 24 hpi and 48 hpi, respectively. Diarrhea, characterized by watery or creamy 
and yellow feces, continued until termination of the study. Clinically, there was no discernable 
difference in the severity of diarrhea between singular or co-infected groups. At necropsy, virus-
inoculated pigs were variably dehydrated and thin and had fecal staining on the peritoneum, 
whereas control piglets were normal with no fecal staining and had formed feces within the 
colon. 
3.2 Pathology 
Grossly, small intestines of virus-inoculated pigs were segmentally thin-walled and spiral 
colons were distended by a large amount of watery contents. There was no apparent difference in 
the severity of gross lesions among the inoculated groups.   
Microscopically, virus-inoculated pigs had varying degrees of villous atrophy in small 
intestines. The degree of villous atrophy, as measured by villous length, for sham- and virus-
inoculated groups is summarized in Figure 1 (pigs necropsied at 24 hpi) and Figure 2 (pigs 
necropsies at 72 hpi). Pigs inoculated with PoRV A had significant villous atrophy only in mid 
jejunum at 24 hpi (p=0.035) and in all segments except duodenum at 72 dpi (p<0.05). In 
comparison, pigs inoculated with PoRV B or C had significant villous atrophy at all segments 
from 24 hpi (p<0.05). All co-infected pigs had significant (p<0.05) villous atrophy in all 
segments at all times except duodenum of group A/B and A/B/C at 24 hpi. 
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There was no significant statistical difference in crypt depth across all treatment groups 
necropsied at 24 hpi. Group A, B, A/C and A/B/C had crypts in duodenum or/and proximal 
jejunum significantly longer than those of sham negative control and group C at 72 hpi.  
3.4 Immunohistochemistry (IHC) and in situ hybridization (ISH) 
 PoRV A and C antigens in intestinal tissues were specifically detected by 
immunohistochemical staining with the MAb 10A11 and 11H3, respectively (Figure 4A and 4C), 
while the MAb 10B1 failed to detect the PoRV B antigen in any of the examined intestinal 
tissues for unknown reasons. As an alternative, an RNAScope® ISH technique was used and 
could detect PoRV B RNA in the tissues (Figure 4B). Using IHC and ISH techniques, 
distribution of PoRV A, B and C in intestinal tissues after experimental inoculation were 
assessed.   
In singularly infected groups, the PoRV B RNA and PoRV A and C antigens were 
detected in villous enterocytes at both 24 hpi and 72 hpi. Distribution-wise, PoRV A, B and C 
were detected in all small intestinal segments at 24 hpi. However, at 72 hpi, PoRV A was 
detected only in proximal jejunum and duodenum while PoRV B and C were found in all 
segments. There was no significant difference in the IHC/ISH scores of PoRV A, B or C among 
all intestine segments. Overall, PoRV A antigen was detected predominantly in jejunum 
(proximal, mid, distal) and ileum at 24 hpi compared to that at 72 hpi. In contrast, PoRV B and C 
distributions in all of the intestinal segments between the two time points were not significantly 
different (Figure 5). 
In co-infected groups, differences in distribution of PoRV A, B, and C between 24 hpi 
and 72 hpi depended on combinations of virus inocula. In group A/B and A/C, no significant 
difference in the distribution of the individual virus in all intestinal segments was observed 
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between the two time points. In group B/C and A/B/C, however, PoRV C antigen was 
predominant in all the segments of small intestine at 24 hpi compared to that at 72 hpi.  
Comparisons between IHC or ISH scores of the PoRV in singular groups and those of co-
infected groups were illustrated in Figure 6. The significant difference in PoRV A IHC scores 
were found between group A and groups A/B, A/C, and A/B/C in the jejunum at 24 hpi (p<0.05) 
and between group A and groups A/C and A/B/C in the ileum at 24 hpi (p<0.05). There was, 
however, no difference in IHC scores between group A and any of co-infected groups at 72 hpi. 
For PoRV B, there was no significant difference in PoRV B ISH scores between group B and 
groups A/B, B/C, and A/B/C in any of the intestinal segments at both time points. Regarding 
PoRV C, the significant differences in IHC score were observed between PoRV C group and co-
infected groups (A/C, B/C, and A/B/C) in duodenum, mid jejunum and proximal jejunum at 72 
hpi although there was no difference between singularly infected and co-infected groups at 24 
hpi,. 
3.5 Fecal shedding of virus 
Fecal shedding of PoRV A, B and C from singularly and co-infected pigs is summarized 
in Table 5 (proportion). Fecal shedding titers of individual PoRV group over time in singularly 
and co-infected groups are illustrated in Figure 7 and Figure 8, respectively.  
First detection of fecal shedding from PoRV A infected pigs was at 24 hpi. Fecal 
shedding continued in 1 of 3 pigs until necropsy at 72 hpi (Table 5), but the viral titer was 
continuously decreased from 24 hpi to 72 hpi (Figure 7). While PoRV A titers in feces at 24, 36, 
48, and 60 hpi were not statistically different, viral titer at 24 hpi was significantly higher 
(p<0.0001) than that at 72hpi. PoRV B fecal shedding was detected in the majority of inoculated 
piglets at 12 hpi and continued in all pigs until their designated necropsy days (Table 5). The titer 
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of PoRV B in feces at 12 hpi was significantly lower (p<0.0001) than that at any other sampling 
times (Figure 7). It is interesting to note that the mean PoRV B titer in feces was gradually 
decreased from 24 to 48 hpi and then increased back from 48 to 72 hpi although any of these 
differences were not statistically significant. The fecal shedding of PoRV C at a high titer was 
detected as early as 12 hpi and remained statistically unchanged until the end of the study (Table 
5 and Figure 7). Overall, the peak shedding of PoRV A, B, and C in feces ranged from 24 to 36 
hpi. The statistical difference in fecal viral titers between virus groups were found only at 12 hpi 
between group A and groups B and C but not between B and C. 
When fecal shedding of individual PoRV group was compared between singularly 
infected and co-infected groups (Figure 8), there were no statistically significant differences 
between groups except PoRV A shedding in group A/C versus that in group A, A/B, and A/B/C 
at 24 hpi (p<0.0001) and PoRV C shedding in group C and A/C versus that in group A/B/C at 12 
hpi (p<0.005). However, when fecal shedding titers of individual rotaviruses within each co-
infected group were compared (Figure 9), the difference in virus shedding was observed 
depending on the combinations. In group A/B, the significant difference in shedding of PoRV A 
and PoRV B was found only at 12 hpi (P <0.05); however, in group A/C, the significant 
difference was observed at 24 hpi (P <0.0001). In group B/C, there was no statistical difference 
between PoRV B and C shedding over time. In group A/B/C, there was a significant difference 
between the shedding of PoRV A or C and that of PoRV B at 12 hpi (P <0.05) and between the 
shedding of PoRV A or B and that of PoRV C at 72hpi. 
IV. Discussion 
 
Since diagnostic laboratory data suggested that PoRV A, B, and C have a different 
prevalence by age group (8), the current study was conducted to assess if PoRV A, B and C 
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differ in their pathogenicity and pathogenesis in CDCD neonatal piglets by exposing the pigs to 
individual group or combinations. All inoculated neonatal CDCD piglets in this study developed 
diarrhea irrespective of group of the virus to which the pigs were exposed. In singularly infected 
piglets, diarrhea was developed between 24 and 48 hpi, which is similar to previous observations 
(14,20,21,22). The severity of diarrhea caused by each of group A, B, and C was not different 
either, which is contradictory to the previous observation that PoRV A and C caused more severe 
diarrhea and dehydration than PoRV B (23). Such a difference may have been attributed to 
variation of virulence among rotavirus strains used or of experiment conditions between studies 
cited in the review article. Furthermore, the onset and severity of diarrhea in piglets was 
comparable between singularly infected group and co-infected group, suggesting no synergistic 
or additive consequence of multiple infections. The lack of synergistic or additive effect of co-
infection was also apparent with pathology in small intestine. It could be speculated that such 
lacking might have been attributed to that the total amounts of viruses in co-infected groups were 
adjusted to be the same as those in singular infected pigs in order to have individual pigs the 
same viral burden. However, the total amount of PoRV shed in co-infected pigs were higher than 
that in singularly infected pigs as shown in Table 5, suggesting that each serogroup of PoRV 
replicated to its full capacity. It is then uncertain that a lower challenge dose of each serogroup in 
co-infected group (i.e., 1 x 103 PFU for co-infected as compared to 3 x 103 PFU for singularly 
infected) had a negative impact leading to no synergistic or additive effect, as the difference in 
viral dose seemed to be negligible in the current study. Thus, it may be necessary to assess a 
minimum infectious dose of each serogroup and study dose response of outcome in pigs exposed 
to mixed infection. 
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All rotavirus challenged piglets developed microscopic lesions of infection, i.e., atrophic 
enteritis, suggesting that the viruses used in this study are virulent in the CDCD piglets. Except 
PoRV A infected piglets, microscopic lesions were present in all examined segments of small 
intestine. In addition, virus antigens (PoRV A and C) or virus RNA (PoRV B) were found in all 
small intestinal segments of piglets singularly infected with the corresponding virus at 24 hpi, 
suggesting that these viruses can equally infect the epithelial cells throughout the small intestine. 
The ability of all 3 PoRV groups to infect all intestinal segments is in agreement with previous 
studies (21, 22, 24). At 72 hpi, PoRV B RNA and PoRV C antigen were still present in all 
intestinal segments of the singularly infected groups. However, PoRV A antigen was only found 
in duodenum and proximal jejunum but not in ileum and mid and distal jejunum that had 
significant villous atrophy. A reason could be that there were not many cells harboring PoRV A 
in ileum and mid and distal jejunum due to villous atrophy at 72 hpi. This agrees with shedding 
data that PoRV A shedding titer at 72 hpi was around 103.1 copies/10µl, reduced more than 103 
copies from that at 24 hpi while PoRV B and C shedding titers were 105.9 and 104.7 copy/10 l, 
respectively. It would mean that PoRV A might replicate faster than PoRV B or C so that it kills 
cells rapidly. An interesting finding was that PoRV A group had significant longer villi in 
duodenal segment at both 24 hpi and 72 dpi compared to other segments in the same group as 
well as those of PoRV B, C or B/C group although the virus antigen were found by IHC in these 
regions at the same time. While some investigators reported that PoRV A infected duodenum 
have longer villi than those in other regions of the small intestine (11, 15, 25), others reported 
that group A rotavirus caused villous atrophy throughout the entire small intestine (14, 24, 26). 
Such a discrepancy may be due to differences of virus strains used in those studies. 
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There was no significant difference in crypt lengths between PoRV C only group and 
negative control until 72hpi, suggesting that the intestinal mucosal recovery in these pigs was 
slower than that of the other groups, such as A, B, A/C, and A/B/C in which the crypt depth of 
duodenum and/or proximal jejunum was increased at 72hpi. Because the replacement time for 
epithelia of small intestinal mucosa in neonatal pigs has been reported to be 7 to 10 days (27), 
the significance of the observed difference in the intestinal mucosal recovery from the disease 
between treatments could not be assessed as the study was terminated at 3 dpi. It is unknown 
why the crypt depth of duodenum was increased in PoRV A infected pigs when the virus seemed 
not to negatively affected the duodenum. 
Singularly infected pigs did not show a significant difference in the virus shedding titer 
from 24 to 72hpi. Fecal shedding pattern among PoRV groups was, however, different. The fecal 
shedding of PoRV B and C was detected by 12 hpi and remained in a high titer until the 
termination of the study (72 hpi). In contrast, PoRV A shedding was detected at 24 hpi, not at 12 
dpi, and gradually decreased from 60 hpi to 72 hpi. This observation suggests that PoRV B and 
C may have longer shedding than PoRV A and was in accordance with the result of IHC and ISH 
showing that PoRV A was detectable only in duodenum and proximal jejunum at 72 hpi. This 
may be related to the difference in replication behavior of the viruses. It can be speculated that 
by 72 hpi, PoRV A may have destroyed villous epithelium so extensively that there were not 
many enterocytes left for virus replication. Interestingly, the shedding of individual PoRV in co-
infected pigs was lower than those in singular groups, which may reflect the fact that pigs were 
exposed to a lower dose of individual PoRV when received multiple groups since all inocula 
were adjusted to contain the same amount of rotaviruses in total. However, such a difference was 
not statistically significant after 24 hpi. In fact, the total amount of all PoRV groups shed in co-
96 
 
 
infected groups were higher than that in singular infected group. Any negative impact, if any, of 
lower challenge dose of individual PoRV group on clinical presentation or pathology in co-
infection groups would be negligible as compared to singular infection groups.   
There was a difference in the virus amount in the intestinal tissues over time between 
PoRV A- and PoRV B and C-infected pigs, indicating that the replication pattern of PoRV A is 
different from those of PoRV B and C used in this study. The amount of PoRV A antigens in the 
small intestine at 72 hpi was significantly lower than that at 24 hpi, which is different from a 
previous report (24) in which the immunofluorescence scores of PoRV A in duodenum, jejunum 
and ileum at 3 dpi were higher than those at 1 dpi. In comparison, the amount of PoRV B and C 
at 24 hpi was not significantly different from that at 72 hpi. The PoRV C data of our study is also 
different from a previous study (22) reporting that the number of cells positive for PoRV C by 
immunofluorescence at 48 hpi was lower than that at 36hpi. It appears that rotaviruses seem have 
different replication pattern among not only groups but also the strains within the same group. 
In conclusion, PoRV A, B, and C were equally pathogenic to CDCD neonatal piglets 
under conditions presented in the study regardless singular infection or co-infection with 
multiple groups. However, it appears that the viruses of different groups may have different 
replication behavior/capability in the gut, resulting in difference in the distribution of the 
microscopic lesions at 24 hpi as well as the starting of virus shedding time point between the 
groups. Therefore, while this neonatal piglet study could not support the difference in the 
pathogenicity among PoRV A, B as we postulated, and C, it may be worthwhile to study the 
replication and pathogenicity of PoRV A, B and C in sows concerning lactogenic immunity to 
piglets as such a study could explain the reported high prevalence of PoRV C in rotavirus-
associated pre-weaning diarrhea. 
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Table 
 
Table 1. Experimental design: One day-old CDCD piglets were randomized into eight treatment 
groups and inoculated with sham (i.e., negative control) or different rotaviral groups singularly 
or in combination 
 
Groups No. of pigs Age Inoculum  
1 6 1 day negative control 
2 6 1 day Rotavirus group A 
3 6 1 day Rotavirus group B 
4 6 1 day Rotavirus group C  
5 6 1 day Rotavirus group A & B 
6 6 1 day Rotavirus group A & C 
7 6 1 day Rotavirus group B & C 
8 6 1 days Rotavirus group A, B, & C 
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Table 2. Sequences of oligonucleotide primers and probes used in quantitative reverse 
transcriptase-polymerase chain reaction assays to detect porcine rotavirus (PoRV) A, B, and C in 
specimens. 
 
Target (reference) Primer sequence 
PoRV A (8) Forward Primer 5′-GCT AGG GAY AAA ATT GTT GAA GGT A-3′ 
Reverse Primer 5′-ATT GGC AAA TTT CCT ATT CCT CC-3′ 
Probe A-1 5′-FAM-ATG AAT GGA AAT GAY TTT CAA AC-MGB-3′ 
Probe A-2 5′-FAM-ATG AAT GGA AAT AAT TTT CAA AC-MGB-3 
PoRV B* Forward Primer: 5’-ATG GAT CTG ATC GAA ACA GTG AAC-3′ 
Reverse Primer 5′- TTG GAG CAA GTA NAA GAA TAC GTT TCT-3′ 
 
Probe 5′-FAM-CATGCGTCAAATTG-MGB-3′ 
PoRV C (8) Forward Primer 5′-ATG TAG CAT GAT TCA CGA ATG GG-3′ 
Reverse Primer 5′-ACA TTT CAT CCT CCT GGG GAT C-3′ 
Probe 5′-VIC-GCG TAG GGG CAA ATG CGC ATG A-TAMRA-3′ 
*The primers and probe were designed in this study. 
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Table 3.  Distribution of porcine rotavirus (PoRV) A, B or C in different regions of the small 
intestine of pig at 24 and 72 hours post inoculation (hpi) with one of the 3 groups as measured by 
immunohistochemistry (A and C) or in-situ hybridization (B) 
*+ or – is equal to one pig 
§Average immunohistochemistry or in-situ hybridization score (0 = no signal, 1 = 1–20% of 
villous enterocytes within the section showing a positive signal, 2 = 21–50% of villous 
enterocytes showing a positive signal, and 3 = greater than 50% of villous enterocytes showing a 
positive signal) 
 PoRV A PoRV B PoRV C 
24 hpi 72 hpi 24 hpi 72 hpi 24 hpi 72 hpi 
Ileum +++* 
2.3§ 
– – 
 
+++ 
1.0 
+– – 
0.3 
++– 
1.0 
++– 
0.7 
Distal jejunum 
 
+++ 
3.0 
– – 
 
+++ 
1.3 
++– 
1 
+++ 
1.3 
–+– 
0.3 
Mid jejunum 
 
+++ 
3.0 
– – 
 
+++ 
1 
++– 
1.3 
+++ 
1.3 
+++ 
1.0 
Proximal 
jejunum 
 
+++ 
3.0 
+– 
0.5 
+++ 
1.7 
++– 
1.3 
+++ 
1.7 
+++ 
1.0 
Duodenum 
 
+++ 
1.3 
++ 
1.0 
+++ 
1.7 
++– 
1.0 
+++ 
1.7 
+++ 
2.0 
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Table 4. Distribution of porcine rotavirus (PoRV) A, B or C in different regions of the small intestine of pig at 24 and 72 hours post 
inoculation (hpi) with combination of the groups as measured by immunohistochemistry (A and C) or in-situ hybridization (B) 
 
 A/B A/C B/C A/B/C 
PoRV A PoRV B PoRV A PoRV C PoRV B PoRV C PoRV A PoRV B PoRV C 
24 72 24 72 24 72 24 72 24 72 24 72 24 72 24 72 24 72 
Ileum ++-* 
1.3§ 
--- +++ 
2.0 
--- 
 
+-- 
0.3 
+-- 
1.0 
++- 
1.3 
--- --- --- +++ 
1.3 
--- ++- 
0.7 
--- --- --- +++ 
1.0 
--- 
Distal 
jejunum 
 
++- 
1.0 
+-- 
1.0 
+++ 
1.5 
+-- 
0.7 
+-- 
0.3 
++- 
1.0 
+-- 
0.7 
--- --- --- +++ 
1.0 
--- +-- 
0.3 
-+- 
0.3 
--- --- +-- 
0.7 
--- 
Mid 
jejunum 
 
+-- 
1.0 
++- 
1.0 
+++ 
1.0 
++- 
1.0 
--- ++- 
1.0 
++- 
1.0 
--- --- --- +++ 
1.3 
--- --- +-- 
0.3 
--- -+- 
0.3 
++- 
1.7 
--- 
Proximal 
jejunum 
 
+-- 
1.0 
--- +++ 
1.0 
++- 
1.3 
++- 
1.0 
++- 
0.7 
++- 
1.3 
+-- 
0.3 
--- --- +++ 
1.7 
--- --- +++ 
1.0 
--- --- +++ 
2.0 
--- 
Duodenum 
 
--- --- +++ 
1.3 
++- 
1.0 
--- --- ++- 
0.7 
+-+ 
0.7 
++- 
0.7 
--- +++ 
2.3 
++- 
0.7 
--- --- +-- 
0.7 
--- ++- 
1.3 
--- 
*+ or – is equal to one pig 
§average immunohistochemistry or in-situ hybridization score (0 = no signal; 1 = 1–20% of villous enterocytes within the section showing a positive signal, 
2 = 21–50% of villous enterocytes showing a positive signal; and 3 = greater than 50% of villous enterocytes showing a positive signal) 
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Table 5. Proportion of pigs shedding porcine rotavirus A, B and/or C in feces and PCR-estimated titers (in the parenthesis) of 
individual rotavirus in fecal swabs from piglets inoculated singularly (A, B, C) or with different combinations (A/B, A/C, B/C, A/B/C) 
of rotaviral groups at given hours post infection (hpi) 
 
*% positives for each target group 
#Not Applicable 
§geometric mean genomic copy number/10µl of respective porcine rotavirus group (log10) 
 
 
 
Virus 
inoculum 
Fecal Shedding pattern at a given time after experimental inoculation 
12 hpi 24 hpi 36 hpi 48 hpi 60 hpi 72 hpi 
A 0* (N/A#) 100 (6.4§) 100 (6.1) 66 (4.3) 66 (4.1) 33 (3.1) 
B 50 (3.8) 50 (5.7) 100 (5.2) 100 (4.7) 100 (5.2) 100 (5.9) 
C 83 (3.98) 100 (4.6) 100 (5.3) 100 (4.9) 100 (4.6) 100 (4.7) 
A/B 0.0 / 33 
(0.0 / 2.7) 
100/100 
(5.3 / 6.3) 
100 / 100 
(5.2 / 5.2) 
67 / 100 
(3.9 / 4.0) 
100 / 100 
(4.5 / 4.2) 
67 / 100 
(3.9 / 4.6) 
A/C 50 / 83 
(2.5 / 4.5) 
0 / 44 
(0.0 / 4.5) 
33/ 100 
(2.4 / 4.0) 
33 / 67 
(3.4 / 4.0) 
33 / 67 
(3.1 / 3.2) 
33 / 67 
(2.5 / 3.0) 
B/C 67 / 50 
(3.3 / 2.3) 
100 / 100 
(4.9 / 5.1) 
100 / 100 
(4.7 / 4.1) 
67 / 67 
(3.2 / 2.1) 
67/ 67 
(2.8 / 2.2) 
67/ 67 
(3.2 / 2.4) 
A /B/C 0 / 17 / 0 
(0.0/ 2.4 / 0.0) 
100 / 100 / 100 
(4.6 / 4.5 / 4.9) 
100 / 100 / 100 
(4.8 / 4.6 / 4.0) 
33 /100 / 67 
(2.6 / 3.4 / 3.0) 
67 /100 / 33 
(3.0 / 3.9 / 1.8) 
100 /100/ 33 
(3.4 / 3.5 / 1.9) 
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Figure 1. Average villous height per small intestinal location (duodenum, proximal 
jejunum, mid jejunum, distal jejunum, ileum) of piglets at 24 hours post inoculation with 
sham (i.e., negative) or porcine rotavirus A, B and/or C singularly or in combination. 
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Figure 2. Average villous height per small intestinal location (duodenum, proximal 
jejunum, mid jejunum, distal jejunum, ileum) of piglets at 72 hours post inoculation with 
sham or porcine rotavirus A, B and/or C singularly or in combination.  
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Figure 3. Average crypt depth per small intestinal location of (duodenum, proximal 
jejunum, mid jejunum, distal jejunum, ileum) of piglets at 72 hours post inoculation with 
sham or porcine rotavirus A, B and/or C singularly or in combination.  
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A)                                                           B)                                                             C) 
Figure 4. Microphotography of immunohistochemical staining of porcine rotavirus (PoRV) A (A) and PoRV C (B) infected 
enterocytes in small intestine by monoclonal antibodies specific for VP6 protein of respective group and in situ hybridization of PoRV 
B (C) using RNAscope® probe specific for VP6 gene of the virus. 
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Figure 5. The distribution and level of porcine rotavirus (PoRV) A, B, and C in various small 
intestine regions (duodenum, proximal jejunum, mid jejunum, distal jejunum and ileum) at 24 
hours post inoculation (hpi) and 72 hpi as determined by either monoclonal antibody-based 
immunohistochemistry (IHC; for PoRV A and C) and RNAScope® in-situ hybridization (ISH; 
for PoRV B). Average immunohistochemistry or in-situ hybridization score (0 = no signal, 
1 = 1–20% of villous enterocytes within the section showing a positive signal, 2 = 21–50% of 
villous enterocytes showing a positive signal, and 3 = greater than 50% of villous enterocytes 
showing a positive signal) 
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Figure 6. Comparison of the distribution and level of porcine rotavirus (PoRV) A, B and C in various 
small intestine regions (duodenum, proximal jejunum, mid jejunum, distal jejunum, ileum) of piglets 
inoculated with the virus singularly (A, B, C) or in combination (A/B, A/C, B/C, A/B/C) at 24 hours post 
inoculation (hpi) and 72 hpi as determined with monoclonal antibody-based immunohistochemistry (IHC; 
for PoRV A and C) and RNAScope® in-situ hybridization (ISH; for PoRV B). Average 
immunohistochemistry or in-situ hybridization score (0 = no signal, 1 = 1–20% of villous enterocytes 
within the section showing a positive signal, 2 = 21–50% of villous enterocytes showing a positive signal, 
and 3 = greater than 50% of villous enterocytes showing a positive signal) 
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Figure7. Titer of porcine rotavirus (PoRV) A, B or C in fecal swabs collected from CDCD 
neonatal piglets inoculated with one of the rotaviruses at given hours post inoculation (HPI).  
Virus titers were estimated using quantitative RT-PCR specific for VP6 gene of each PoRV 
group. 
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Figure 8.  Titer of porcine rotavirus (PoRV) A, B or C in fecal swabs collected from CDCD 
neonatal piglets inoculated with one or in combinations of the rotaviruses at given hours post 
inoculation (HPI). Virus titers were estimated using quantitative RT-PCR specific for VP6 gene 
of each PoRV group. 
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Figure 9. Titer of porcine rotavirus (PoRV) A, B or C in fecal swabs collected from CDCD 
neonatal piglets inoculated with combinations of the rotaviruses at given hours post inoculation 
(HPI). Virus titers were estimated using quantitative RT-PCR specific for VP6 gene of each 
PoRV group. 
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Abstract 
Group C porcine rotaviruses have been found predominantly in piglets of pre-weaning ages; 
however, there is no commercial vaccine available to mitigate the problem. One of reasons is 
that virus isolation and sustainable propagation has been difficult and not reproducible. Since 
MA-104 cell based virus isolation protocol failed to support isolation of non-group A rotaviruses, 
attempts were made to establish a reliable virus isolation method using different cell lines for 
porcine rotavirus C. As a result, a porcine rotavirus C strain (IA/2015) was successfully isolated 
and maintained using IPEC-1 cell based roller culture system with incorporation of a relatively 
high concentration of trypsin. By sequencing for VP4, V6, and VP7, the genotypes of the virus 
was identified as G6P[5]I5. The isolate and the newly established virus isolation/cultivation 
method may be useful for pathobiology studies, diagnostics and vaccine development. 
I. Introduction 
The rotaviral enteric disease is common in pigs, which causes considerable economic loss 
to the swine industry (1) . The causative agent, porcine rotavirus (PoRV), belongs to genus 
Rotavirus in the family Reoviridae. Rotaviruses are divided into ten groups (A-J) base on the 
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cross-antigenicity and sequence of VP6 protein/gene (2-5). Of them, serogroup A, B, C, E, and H 
have been reported to cause or implicated in enteric disease in pigs (6, 7).   
Generally rotavirus is fastidious to be isolated. Porcine rotavirus A has been isolated 
using an African green monkey kidney derived cell line MA-104 with the presence of a 
proteolytic enzyme, such as trypsin, in cell culture media (8, 9, 10). The successful rate of PoRV 
A isolation using MA-104 cells was reported to be approximately 40% in one study (11). 
Isolation of non-group A porcine rotaviruses, however, has been problematic and sparse because 
MA-104 cells are not permissive to them. Although there were reports of successful isolation of 
PoRV B using swine kidney (SKL) cells (12) and PoRV C using primary pig kidney cells (13), 
none of those protocols has been reproducible as no other PoRV B or C isolates are not available. 
There is no commercial non-group A porcine rotavirus isolates or vaccines available either. As a 
result, researches of pathobiology, immunology, diagnostics, and prophylaxis for non-group A 
porcine rotaviruses have been hindered even though data from the veterinary diagnostic 
community recently demonstrated identification of non-group A rotaviruses in diarrheic pigs as 
frequently as rotavirus A, raising the need for an effective laboratory method to isolate and 
propagate non-group A rotaviruses. 
IPEC-1 cells are derived from a mixture of jejunum and ileum tissues from a neonatal 
piglet while IPEC-J2 cells are isolated from porcine ileum tissue. Both cell lines were originated 
from 1-day old piglets (14). Because these two cell lines are made of non-transformed cells and 
can form polarized columnar cell monolayers, they have been considered good in vitro tools for 
studying the interaction of host cell-virus, bacteria, or toxin and metabolism of some substances 
(15,16,17). IPEC-J2 was reported to support the growth of porcine enteric coronaviruses, such as 
transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV) (18), 
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and especially, porcine rotavirus A (19). Thus, IPEC-1 and IPEC-J2 cells could also support 
isolation and propagation of non-group A rotaviruses. The present study was conducted to 
determine if an in vitro virus isolation system for non-group A rotaviruses especially PoRV C 
can be established using any of these IPEC cell lines. 
II. Materials and Methods 
2.1 Cells 
The IPEC-1 and IPEC-J2 were kindly provided by Dr. Dennis Black (University of 
Tennessee Health Science Center, Memphis, Tennessee) and Dr. Bruce D. Schultz (Kansas State 
University, Manhattan, Kansas), respectively. IPEC-1 was also purchased from a commercial 
source (Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 
Braunschweig, Germany). The cells were cultured in DMEM/F12 media (ThermoFisher 
Scientific, Walham, Massachusetts) supplemented with 5% fetal bovine serum (FBS) (Atlas 
Biological, Fort Collins, Colorado), 5ng/ml epidermal growth factor (Sigma-Aldrich, St. Louis, 
Missouri), 1% insulin-transferrin-selenium (ThermoFisher Scientific), and antibiotics containing 
100 units/ml penicillin and100µg/ml streptomycin (Sigma-Aldrich), hereafter growth media. The 
cells were maintained in 37°C with 5% CO2. The subculture was mostly done at the splitting 
ratio of 1:3 and the confluent monolayer formed in 2 days. 
2.2 Inocula 
Inocula were prepared from intestinal contents which were determined to be positive for 
PoRV B or C by PCR testing. The intestinal contents were obtained from experimental neonatal 
pigs orally inoculated with PoRV B (2011025309A) or PoRV C (2010025060H) purified from a 
positive intestinal content of CDCD pig as described elsewhere (20). Briefly, the fecal samples 
were diluted 1:10 in phosphate-buffered saline (PBS), pH 7.2, and then centrifuged for 15 
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minutes at 5000 x g. The resulting supernatants were filtered through 0.2µm Costar membrane 
filters (Sigma-Aldrich) before use. The PoRV A isolate (ISU2010035768) was used as positive 
control. 
2.3 Virus isolation 
 The virus isolation was attempted as previously described (13) with modifications. Cells 
were seeded to Corning roller culture tubes, 16x125mm in size (Sigma-Aldrich) at the rate of 3 x 
105 cells/tube in 5ml of growth media. All tubes were inserted into a roller drum placed in a 
water-jacketed CO2 incubator. When cell monolayers were formed (generally 2 days after 
seeding), the cells were washed 3 times with DMEM/F12 supplemented with the penicillin-
streptomycin approximately 3 hours before inoculation. One hour before inoculation, 95µl of 
each processed fecal sample were mixed with 5µl trypsin (200µg/ml) and incubated for one hour 
at 37°C. Afterward, cell monolayers were incubated with 100µl of the treated inoculum for 2 
hours at 37°C. Each inoculum was run in duplicate. Finally, 2ml of the maintenance media were 
added to each tube. The maintenance media was the same as growth media without FBS which 
was supplemented with 5µg/ml trypsin (ThermoFisher Scientific) and 10% tryptose phosphate 
broth (Sigma-Aldrich). The cells were checked every day for cytopathic effect (CPE) in 3 days. 
Subsequently, the cells were frozen-and-thawed 3 times and used as inoculum for the next cell 
culture passage. Subculture was done in the identical manner as described above. After each 
passage, the cell supernatant was tested by a real time RT-PCR for PoRV C as described below. 
The inoculum was considered as negative when the cycle threshold (Ct) value was higher than 
30. 
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2.4 Confirmation of virus growth 
2.4.1 Real-time RT-PCR 
One hundred and forty microliters of cell culture media from inoculated cells were taken 
to extract RNA using QIAamp® Viral RNA Mini kit (QIAGEN, Valencia, California) as per 
procedure recommended by the manufacturer. Subsequently, the RNA extract was tested by real-
time RT-PCRs specific for PoRV A, B and C as previously reported (21). The 10-fold serial 
dilutions of plasmids containing known copy numbers of PoRV C VP6 gene were used as 
standards to estimate viral titers. 
2.4.2 Immunofluorescence assay 
The IPEC-1 cells were seeded at the concentration of 3 x 105 in a Lab-Tek™ SlideFlask 
chamber (ThermoFisher Scientific) which, after that, was attached to a 15ml plastic centrifuge 
tube and placed in a roller drum. Two days later, resulting cell monolayers were inoculated with 
100µl of the trypsin-treated virus inoculum and incubated for 2 hours at 37°C, then replenished 
with 2ml of the maintenance media. After 24 hours post inoculation, the cells were fixed with 
2ml of cold 80% acetone aqueous solution. The cells were first incubated with a monoclonal 
antibody specific for VP6 of PoRV C (2010025060H) (22) for 1 hour at 37°C. After washing 3 
times with PBS, the presence of virus-antibody mixture were visualized by staining with goal 
anti-mouse IgA+IgG+IgM (H+L) polyclonal antibody conjugated with fluorescein 
isothiocyanate (Seracare, Milford, MA). After washing, the stained cells were observed under a 
fluorescent microscope for the rotavirus-specific signal. 
2.4.3 Immunoelectron microscopy (IEM) 
Thirty milliliters of cell-cultured virus material were clarified by ultracentrifugation at 
100000 x g on a 35% sucrose cushion as previously described (23). The resulting pellet was 
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resuspended in TNC buffer (0.4mM Tris/HCl, 2mM NaCl, 10µM CaCl2) and ultracentrifuged 
again in the identical manner as described above. Then 200 µl of deionized water was added to 
the pellet and left overnight at 4°C. The virus was resuspended by dispersing the pellet using a 
syringe with 18G needle. The virus was incubated with anti-PoRV C VP6 monoclonal antibody 
produced in our laboratory (22) for 1 hour at 37°C and centrifuged for 15000 x g for 30 minutes. 
Then, the pellet containing virus was stained with 2% uranyl acetate and examined under a 
transmission electron microscope at Roy J. Carver High Resolution Microscopy Facility, Iowa 
State University. 
2.5 Sequencing and sequence analysis 
The V4, VP6, and VP7 genes were amplified by using the primers listed in Table 1. The 
amplified products were purified by QIAquick gel extraction kit (QIAGEN) by following 
manufacturer’s recommended procedures and sequenced by the Sanger method at the Iowa State 
University DNA Facility. Sequences were assembled by Lasergene’s SeqMan Pro (DNASTAR®, 
Madison, Wisconsin). The sequences of VP4, VP7, and VP6 genes were then comparatively 
analyzed with other corresponding sequences of rotaviruses available in GenBank® (National 
Center for Biotechnology Information, Bethesda, MD) using Lasergene’s MegAlign 
(DNASTAR®). In addition, the phylogenetic analyses were completed by using maximum 
likelihood method in MEGA software, version 7 (24).  
III. Results  
3.1 Virus isolation 
PoRV A-inoculated IPEC-1 cell lines in the first passage showed CPE manifested by 
cells death and detaching from growing surface of cell culture tubes from 48 hours post 
inoculation. However, the cytolytic changes by PoRV B or C in IPEC-1 or IPEC-J2 were not 
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clearly discernable between inoculated cells and uninoculated cells (i.e., negative control) by the 
time cell culture fluids were ready to be harvested for testing.  
When cell culture supernatants collected after each passage of virus material were tested 
by PCR to monitor virus growing, the Ct value of PoRV C-inoculated IPEC-J2 cell culture 
supernatant after the 5th passage was 33.0 which was higher than that of the original inoculum 
(Ct=28.0), whereas the Ct value of PoRV C-inoculated IPEC-1 cell culture supernatant after the 
5th passage was 22.9 which was lower than that of the original inoculum. Since IPEC-J2 seemed 
not to support PoRV C growth, the cell was not used in further blind passages of PoRV C 
material. The Ct value of PoRV B-inoculated IPEC-1 and IPEC-J2 cell culture supernatant after 
the 5th passage are 35.9, which were higher than that of the original inoculum (Ct=27.5), 
suggesting that both IPEC cells did not support PoRV B growth. No further blind passage of 
PoRV B was made after passage 5.   
As shown in Table 2, the titer of PoRV C appeared to be gradually increased from 
passage 1 (104.8 genomic copy number/10μl) to passage 7 (107.6 genomic copy number/10μl) in 
IPEC-1 cells as estimated by quantitative real-time RT-PCR and remained stable during further 
cell culture passages, suggesting that the virus was growing and adapted to IPEC-1 cells. All cell 
culture supernatants collected from PoRV C inoculated IPEC-1 cells during serial passages were 
negative by the real-time RT-PCR for PoRV A and PoRV B. 
Under electron microsope, wheel-shaped non-enveloped virus partices of 60 nm in 
diameter, which was simliar to the morphology of members of Reoviridae, were observed from 
cell culture supernatant harvested after 20 passages (Figure 1). Since virions were aggregated by 
adding PoRV C-specific antibody for IEM, the virus in the cell culture supernatants was 
determined to be a rotavirus. Immunofluorescence microscopy using PoRV C VP6-specific 
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monoclonal antibody (11H3) confirmed the presence of PoRV C in IPEC-1 cells after 24 hours 
post inoculation, suggesting viral growth in the cell. The infected cells with fluorescence were 
clearly visible in the cytoplasm whereas there was no fluorescence from sham-inoculated 
negative control cells (Figure 2). The PoRV C isolate was then designated IA/2015. 
3.2 Molecular characterization of porcine rotavirus C IA/2015 isolate 
VP4, VP7, and VP6 sequences of the IA/2015 isolate were successfully obtainted. For 
VP4 gene, the nucleotide similarity between the IA/2015 and 23 reference strains representing 8 
P genotypes (P1 to P8) ranged from 69.9% to 88.9% (Table 3). Of them, VP4 sequence of the 
isolate showed the highest similarity to those belonging to the P[5] genotype, ranging from 
81.2% to 88.9%. As such, the IA/2015 isolate was classified as P[5] when the 83% nucleotide 
identity was applied as cut-off as previously described (25). The phylogenetic analysis based on 
VP4 sequences showed that the IA/2015 strain was closely realated to and clustered with PoRV 
C KOR/07-60-4, USA/RV0143, JPN/CJ13-6, and JPN/134-9, which were all P[5] genotype, as 
illustrated in Figure 3.  
The nucleotide similarity of VP7 gene between the IA/2015 isolate and 32 PoRV C 
reference strains representing 13 G types ranged from 48.6% to 94.7% as summarized in Table 4. 
The isolate was classified as G6 when the 85% nucleotide identity was applied as cut-off as 
previously proposed (26). Phylogenetically, the new isolate was clustered with G6 PoRV C 
CAN/MB11-58, USA/NE09-2, CAN/MB-11-57, and USA/IL10-49 (Figure 4). 
Based on the 90% nucleotide identity of VP6 as cut-off (25), the IA/2015 isolate of PoRV 
C was determined to be I5 genotype. The VP6 nuleotide identity between the new isolate and 
other PoRV C representing 7 I types ranged from 80.0% to 93.5% as shown in Table 5. Figure 5 
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illustrates that the isolate is phylogenetically close to and clustered with KOR/06-92-1, KOR/06-
146-2, USA/RV0143, and USA/RV0104 based on VP6 sequence. 
IV. Discussion 
Porcine rotavirus C is an important enteric viral pathogen in pigs and has been most 
commonly identified in pre-weaning piglets with diarrhea (1-21 days of age) as compared to 
PoRV A and B being common in older piglets (21, 26). Frequent identification of PoRV C in 
neonatal and nursing piglets raised the need for better prophylaxis leading to good lactogenic 
immunity in young piglets. However, it has been historically a great challenge, if not possible, to 
isolate PoRV C, resulting in lack of virus isolates which can be used to study pathobiology or to 
develop diagnostics and prophylatic methods includig vaccines. The current study shed a light on 
a possible in vitro method for isolating PoRV C reliably as the study showed successful isolation 
of PoRV C from intestinal contents using IPEC-1 cells as well as substainable maintenance of 
the virus in the cells over 20 serial passages. The same method was also applied to a limited 
number of clinical specimens submitted to Iowa State University Veterinary Diagnostic 
Laboratory which were positive for PoRV C by PCR and resulted in successful isolation of 
PoRV C (data not shown), suggesting that the newly established method can be an effective in 
vitro virus isolation technique for group C porcine rotaviruses with a reasonable recovery rate.   
The IPEC-1 cells are immortalized enterocytes originated from a mixture of ileum and 
jejunum tissue from 1-day old piglets. As mature enterocytes of small intestine is the main 
natural host cell for rotaviruses in pigs, IPEC-1 cells were expected to support porcine rotavirus 
infection and replication and to maintain the natural characteristics of the virus, which was 
demonstrated in the current study for PoRV A and C but not for PoRV B. Reasons for the failure 
of cultivating PoRV B in IPEC-1 cells are unknown and remain to be further investigated. 
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Nonetheless, IPEC-1 cells may serve as an in vitro model for studying the pathobiology of 
porcine rotaviruses. 
Proteases, such as pancreatin and trypsin, are known to be required for in vitro rotavirus 
cultivation (27). For isolation of PoRV C, use of a high concentration of such a proteolytic 
enzyme in media was recommended (28). However, a high concentraiton of trypsin (5µg/ml) in 
the maintenance media was somewhat detrimental to viability and integrity of IPEC-1 cells in 
this study. As a consequence, monitoring for the development of virus-associated CPE was not 
as clear and easy as should be since approximatly 20 to 30% of cells died and were detached 
from the growing surface of cell culture plasticware unrelated to virus infection or growth after 2 
or 3 days post inoculation. Therefore, it was necessary to confirm the virus replication in IPEC-1 
cell culture using other laboratory methods such as PCR or immunofluorescence test besides 
CPE obseravtion. Furthremore, because several blind passages were necessary to confirm the 
isolation and propagation of PoRV C, use of a PCR-based assay in a quantitative manner was 
found to be beneficial for rapid screening of cell culture media for virus growth.    
Unlike rotavirus A, there is no thorough classification system for group C rotaviruses. 
Nevertheless, it is important to determine G and P types of an isolate as VP7 and VP4 are known 
to contain neutralizing epitopes related to cross-protective immunity (29, 30). To determine the 
G genotype of isolate, the 85% (26) or 86% (31) VP7 nucleotide identity to rotaviruses with 
known G types has been proposed as cut-off, which result in 9 or 13 G genotypes, respectively. 
Of them, G1, 3, 5, 6, 7, 8, 9, 10, 12, and 13 have been detected in clinical specimens from 
diarrheic pigs (32). The PoRV C IA/2015 isolate was determined to be G6 and closely related to 
the North America PoRV C strains CAN/MB11-58, USA/NE09-2, CAN/MB11-57, and USA/IL 
10-49 based on VP7 sequence. Noteworthy, G6 has been the most common G type detected in 
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pigs associated with rotavirus infection in the U.S., Canada (26), Brazil (33), and Italy (34). It 
has also been reported in Ireland (35), Korea (36), and Czech Republic (32), indicating that G6 
may be widely distributed in pig-producing regions worldwide. For P type classification, Suzuki 
et al (37) initially proposed 80% VP4 nucleotide identity as cut-off, which classified rotaviruses 
into 6 P types (1-6). The 83% identity as cut-off has also been suggested by other investigators 
(25), (32) which divides rotaviruses into 7 or 8 genotypes. Based on VP4 sequence, the isolate 
was typed to be P[5] and was phylogenetically closer to Korean strain KOR/07-60-4 of PoRV C 
than USA/RV0143 strain of PoRV C. It should be noted though that such a phylogenetic 
relationship may not reflect the real situation because there are a limited number of PoRV C VP4 
sequences from US swine available in the public domain. Thus, more VP4 gene sequencing is 
necessary to have better understanding of PoRV C epidemiology and genotype frequency in US 
swine. Interestingly, the G6P[5] has been reported to be dominant in Japan (37) and Brazil (33). 
Although G6P[5] has been identified  in US swine (38), its prevalence is not known. 
In conclusion, IPEC-1 cell based roller culture system with incorporation of a high 
concentration of trypsin in the maintenance media may be an effective in vitro virus isolation and 
cultivation technique for group C porcine rotaviruses. As the newly established method provides 
sustainable replication of PoRV C at a relatively high titer, the method may also be useful for 
development of whole virus-based vaccines and diagnostics for PoRV C. 
 
 
 
 
 
124 
 
 
References 
1.  Holtkamp D, Rotto H, Garcia R. 2007. Economic cost of major health challenges in large 
US swine. Swine News, vol 30. North Carolina Cooperative Extension Service. 
2. Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M, Johne R. 2012. VP6-
sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol 
157:1177-1182. 
3. Trojnar E, Otto P, Johne R. 2009. The first complete genome sequence of a chicken 
group A rotavirus indicates independent evolution of mammalian and avian strains. 
Virology 386:325-333. 
4. Mihalov-Kovács E, Gellért Á, Marton S, Farkas SL, Fehér E, Oldal M, Jakab F, Martella 
V, Bányai K. 2015. Candidate new rotavirus species in sheltered dogs, Hungary. Emerg 
Infect Dis 21:660-663. 
5. Bányai K, Kemenesi G, Budinski I, Földes F, Zana B, Marton S, Varga-Kugler R, Oldal 
M, Kurucz K, Jakab F. 2017. Candidate new rotavirus species in Schreiber's bats, Serbia. 
Infect Genet Evol 48:19-26. 
6. Chasey D, Davies P. 1984. Atypical rotaviruses in pigs and cattle. Vet Rec 114:16-7. 
7. Marthaler D, Rossow K, Culhane M, Goyal S, Collins J, Matthijnssens J, Nelson M, 
Ciarlet M. 2014. Widespread rotavirus H in commercially raised pigs, United States. 
Emerg Infect Dis 20:1195-1198. 
8. Fukusho A, Shimizu Y, Ito Y. 1981. Isolation of cytopathic porcine rotavirus in cell roller 
culture in the presence of trypsin. Arch Virol 69:49-60. 
9. Paul PS, Lyoo YS, Andrews JJ, Hill HT. 1988. Isolation of two new serotypes of porcine 
rotavirus from pigs with diarrhea. Arch Virol 100:139-143. 
10. Zhang H, Zhang Z, Wang Y, Wang X, Xia M, Wu H. 2015. Isolation, molecular 
characterization and evaluation of the pathogenicity of a porcine rotavirus isolated from 
Jiangsu Province, China. Arch Virol 160:1333-1338. 
11. Benfield DA, Stotz IJ, Nelson EA, Groon KS. 1984. Comparison of a commercial 
enzyme-linked immunosorbent assay with electron microscopy, fluorescent antibody, and 
virus isolation for the detection of bovine and porcine rotavirus. Am J Vet Res 45:1998-
2002. 
12. Sanekata T, Kuwamoto Y, Akamatsu S, Sakon N, Oseto M, Taniguchi K, Nakata S, Estes 
MK. 1996. Isolation of group B porcine rotavirus in cell culture. J Clin Microbiol 34:759-
761. 
13. Terrett LA, Saif LJ. 1987. Serial propagation of porcine group C rotavirus (pararotavirus) 
in primary porcine kidney cell cultures. J Clin Microbiol 25:1316-1319. 
14. Berschneider  H. 1989. Development of normal cultured small intestinal epithelial cell 
lines which transport Na and Cl.  Abstract of the Annual Meeting of the American 
Gastroenterological Association. 
15. Koh SY, George S, Brözel V, Moxley R, Francis D, Kaushik RS. 2008. Porcine intestinal 
epithelial cell lines as a new in vitro model for studying adherence and pathogenesis of 
enterotoxigenic Escherichia coli. Vet Microbiol 130:191-197. 
16. Botić T, Klingberg TD, Weingartl H, Cencic A. 2007. A novel eukaryotic cell culture 
model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 
115:227-234. 
125 
 
 
17. Brosnahan AJ, Brown DR. 2012. Porcine IPEC-J2 intestinal epithelial cells in 
microbiological investigations. Vet Microbiol 156:229-237. 
18. Zhao S, Gao J, Zhu L, Yang Q. 2014. Transmissible gastroenteritis virus and porcine 
epidemic diarrhoea virus infection induces dramatic changes in the tight junctions and 
microfilaments of polarized IPEC-J2 cells. Virus Res 192:34-45. 
19. Liu F, Li G, Wen K, Bui T, Cao D, Zhang Y, Yuan L. 2010. Porcine small intestinal 
epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate 
immune responses to rotaviruses and probiotics. Viral Immunol 23:135-149. 
20. Hoang H, Madson D, Arruda P, Stevenson G, Yoon K-J. Comparative pathogenicity of 
porcine rotavirus group A, B and C in neonatal pigs. Proceedings of Conference of 
Eesearch Workers in nimal siseases., p 160.    
21. Marthaler D, Homwong N, Rossow K, Culhane M, Goyal S, Collins J, Matthijnssens J, 
Ciarlet M. 2014. Rapid detection and high occurrence of porcine rotavirus A, B, and C by 
RT-qPCR in diagnostic samples. J Virol Methods 209:30-34. 
22. Hoang H, Madson D, Dercheid R, Miller C, Groeltz-Thrush J, Sun D, Yoon K-J. 2016. 
Development of murine monoclonal antibodies for porcine rotavirus group B and C and 
use in immunoassays. Proceedings of International Pig Veterinary Society Congress, 
Dublin, Ireland, p455. 
23. Arnold M, Patton JT, McDonald SM. 2009. Culturing, storage, and quantification of 
rotaviruses. Curr Protoc Microbiol Chapter 15:Unit 15C.3. 
24. Kumar S, Stecher G, Tamura K. 2016. MEGA7: Molecular Evolutionary Genetics 
Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol 33:1870-1874. 
25. Jeong YJ, Matthijnssens J, Kim DS, Kim JY, Alfajaro MM, Park JG, Hosmillo M, Son 
KY, Soliman M, Baek YB, Kwon J, Choi JS, Kang MI, Cho KO. 2015. Genetic diversity 
of the VP7, VP4 and VP6 genes of Korean porcine group C rotaviruses. Vet Microbiol 
176:61-69. 
26. Marthaler D, Rossow K, Culhane M, Collins J, Goyal S, Ciarlet M, Matthijnssens J. 
2013. Identification, phylogenetic analysis and classification of porcine group C rotavirus 
VP7 sequences from the United States and Canada. Virology 446:189-198. 
27. Theil KW, Bohl EH, Agnes AG. 1977. Cell culture propagation of porcine rotavirus 
(reovirus-like agent). Am J Vet Res 38:1765-1768. 
28. Terrett LA, Saif LJ, Theil KW, Kohler EM. 1987. Physicochemical characterization of 
porcine pararotavirus and detection of virus and viral antibodies using cell culture 
immunofluorescence. J Clin Microbiol 25:268-272. 
29. Taniguchi K, Hoshino Y, Nishikawa K, Green KY, Maloy WL, Morita Y, Urasawa S, 
Kapikian AZ, Chanock RM, Gorziglia M. 1988. Cross-reactive and serotype-specific 
neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of 
antigenic mutants selected with monoclonal antibodies. J Virol 62:1870-1874. 
30. Greenberg HB, Flores J, Kalica AR, Wyatt RG, Jones R. 1983. Gene coding assignments 
for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains 
of human rotavirus. J Gen Virol 64:313-320. 
31. Niira K, Ito M, Masuda T, Saitou T, Abe T, Komoto S, Sato M, Yamasato H, Kishimoto 
M, Naoi Y, Sano K, Tuchiaka S, Okada T, Omatsu T, Furuya T, Aoki H, Katayama Y, 
Oba M, Shirai J, Taniguchi K, Mizutani T, Nagai M. 2016. Whole genome sequences of 
Japanese porcine species C rotaviruses reveal a high diversity of genotypes of individual 
126 
 
 
genes and will contribute to a comprehensive, generally accepted classification system. 
Infect Genet Evol 44:106-113. 
32. Moutelíková R, Prodělalová J, Dufková L. 2015. Diversity of VP7, VP4, VP6, NSP2, 
NSP4, and NSP5 genes of porcine rotavirus C: phylogenetic analysis and description of 
potential new VP7, VP4, VP6, and NSP4 genotypes. Arch Virol 160:1715-1727. 
33. Possatti F, Lorenzetti E, Alfieri AF, Alfieri AA. 2016. Genetic heterogeneity of the VP6 
gene and predominance of G6P[5] genotypes of Brazilian porcine rotavirus C field 
strains. Arch Virol 161:1061-1067. 
34. Martella V, Bányai K, Lorusso E, Decaro N, Bellacicco A, Desario C, Corrente M, Greco 
G, Moschidou P, Tempesta M, Arista S, Ciarlet M, Lavazza A, Buonavoglia C. 2007. 
Genetic heterogeneity in the VP7 of group C rotaviruses. Virology 367:358-366. 
35. Collins PJ, Martella V, O'Shea H. 2008. Detection and characterization of group C 
rotaviruses in asymptomatic piglets in Ireland. J Clin Microbiol 46:2973-2979. 
36. Jeong YJ, Park SI, Hosmillo M, Shin DJ, Chun YH, Kim HJ, Kwon HJ, Kang SY, Woo 
SK, Park SJ, Kim GY, Kang MI, Cho KO. 2009. Detection and molecular 
characterization of porcine group C rotaviruses in South Korea. Vet Microbiol 138:217-
224. 
37. Suzuki T, Hasebe A, Miyazaki A, Tsunemitsu H. 2015. Analysis of genetic divergence 
among strains of porcine rotavirus C, with focus on VP4 and VP7 genotypes in Japan. 
Virus Res 197:26-34. 
38. Amimo JO, Vlasova AN, Saif LJ. 2013. Prevalence and genetic heterogeneity of porcine 
group C rotaviruses in nursing and weaned piglets in Ohio, USA and identification of a 
potential new VP4 genotype. Vet Microbiol 164:27-38. 
39. Cooke SJ, Clarke IN, Freitas RB, Gabbay YB, Lambden PR. 1992. The correct sequence 
of the porcine group C/Cowden rotavirus major inner capsid protein shows close 
homology with human isolates from Brazil and the U.K. Virology 190:531-537. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
 
 
Table 
Table 1. Primers used for PCR amplification and sequencing of VP7, VP4, Vp6 gene. 
 Forward primer Reverse primer reference 
VP7 GCTGTCTGACAAACTGGTC GCCACATGATCTTGTTTACGC (38) 
VP4-1 GATCRATGGCGTCYTCAC CCTGATGAATGTAATCCWGGAT 
VP4-2 GATTATTGGGACGATTCAG AGCCACATTTCAAGCTGGTC 
VP6 GGCATTTAAAATCTCATTCAC AGCCACATAGTTCACATTTC (39) 
 
 
 
Table 2. Real-time RT-PCR assessment of porcine rotavirus C growth in IPEC-1 cells over 20 
continuous passages 
 
Passage No. 1 2 3 4 5 6 7 8 9 10 20 
Observed Ct 
value in cell 
culture 
supernatant 
26.9 25.3 24.9 25.3 22.9 20.7 17.3 20.5 19.6 18.5 20.3 
Estimated 
genomic copy 
numbers/10µl 
104.8 105.3 105.4 105.3 106.0 106.6 107.6 106.7 106.9 107.0 106.7
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Table 3. Nucleotide sequence identity for VP4 between porcine rotavirus C IA/2015 and 
reference strains whose sequences are available in GenBank 
 
GenBank accession number P types % nucleotide identity with 
IA/2015 
M74218 P1          73.4 
KJ814468.1 P1 73.9 
KP776602.1 P2 70.4 
KP776601.1 P2 70.3 
LC129057.1 P2 70.3 
LC129052.1 P2 69.9 
AB874624.1 P3 76.2 
AB874627.1 P3 73.0 
AB874625.1 P3 73.8 
AB874628.1 P3 73.2 
LC122622.1 P4 71.9 
LC122590.1 P4 72.7 
KJ814472.1 P5 81.2 
KJ814469.1 P5 88.9 
KC164679.1 P5 88.4 
AB905251.1 P5 88.3 
AB905233.1 P5 88.4 
KJ814475.1 P6 70.9 
KJ814476.1 P6 71.2 
KJ814471.1 P7 72.0 
KJ814474.1 P7 72.9 
KM099262.1 P8 72.6 
KM099261.1 P8 72.6 
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Table4. Nucleotide sequence identity for VP7 between porcine rotavirus C IA/2015 and 
reference strains whose sequences are available in GenBank 
 
GenBank accession number G types % nucleotide identity with 
IA/2015 
JX273364.1 G1          78.6 
JX273310.1 G1 76.0 
M61101.1 G1 76.4 
U31750.1 G2 76.5 
KJ814494.1 G3 72.5 
KJ814491.1 G3 72.8 
KT355398.1 G4 77.9 
KT206193.1 G4 77.1 
JX273357.1           G5 77.4 
JX273324.1 G5 77.3 
JX273312.1 G5 77.7 
JX273354.1 G6 89.4 
JX273355.1 G6 94.7 
KJ814500.1 G6 86.9 
KJ814498.1 G6 89.9 
KJ814496.1 G6 89.8 
JX273346.1 G6 89.9 
JX273350.1 G6 86.8 
JX273327.1 G6 89.4 
JX273321.1 G6 90.0 
JX273301.1 G6 86.3 
JX273299.1 G6 91.0 
JX273298.1 G6 89.3 
JX273318.1 G6 89.8 
KJ814509.1 G7 75.2 
KJ814508.1 G7 75.2 
KF500212.1 G8 49.0 
FJ807863.1 G8 49.0 
FJ807861.1 G8 48.6 
KT820780.1 G9 51.2 
KT820776.1 G9 50.4 
JQ343835.1 G9 51.2 
KM099271.1 G10 78.0 
KP988018.1 G11 76.5 
LC122610.1 G12 81.6 
LC122621.1 G13 77.4 
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Table 5. Nucleotide sequence identity for VP6 between porcine rotavirus C IA/2015 and 
reference strains whose sequences are available in GenBank 
 
GenBank Accession number I types % nucleotide identity with 
IA/2015 
M94157.1 I1          86.8 
AB889510.1 I1 83.8 
KP776604.1 I2 82.6 
KP776603.1 I2 81.9 
LC129065.1 I2 82.6 
AB874631.1 I3 83.0 
AB874632.1 I3 83.0 
AB874633.1 I3 83.0 
AB874635.1 I3 82.9 
AB889507.1 I4 87.2 
KJ814482.1 I4 86.5 
GQ925781.1 I4 87.7 
FJ494690.1 I5 93.3 
KC164674.1 I5 93.2 
FJ494692.1 I5 93.5 
KC164677.1 I5 93.2 
HQ323753.1 I6 80.5 
HQ833829.1 I6 80.5 
KJ814478.1 I7 84.5 
KJ814479.1 I7 84.9 
FJ494691.1 I7 84.6 
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Figure 
 
Figure 1. Electron microscopic photography of porcine rotavirus (PoRV) C particles from IPEC-
1 cell culture supernatant which were aggregated by PoRV C-specific monoclonal antibody 
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Figure 2. Immunofluorescence staining of porcine rotavirus C IA/2015 in IPEC-1 cells at 24 
hours post inoculation (left) by porcine rotavirus C VP6-specific monoclonal antibody as 
compared to negative staining of sham-inoculated IPEC-1 (right) 
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Figure 3. Phylogenetic relationship of porcine rotavirus C IA/2015 isolate (indicated by the red 
square) with other group C porcine rotaviruses based on VP4 sequence 
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Figure4. Phylogenetic relationship of porcine rotavirus C IA/2015 isolate (indicated by the red 
square) with other group C porcine rotaviruses based on VP7 sequence 
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Figure 5. Phylogenetic relationship of porcine rotavirus C IA/2015 isolate (indicated by the red 
square) with other group C porcine rotaviruses based on VP6 sequence 
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CHAPTER5. GENERAL CONCLUSIONS  
Historically, rotavirus A has been believed to be the major cause of rotavirus-associated 
diarrhea in young pigs even though the presence of non-group A rotaviruses in swine was 
reported, probably due to difficulty of isolating non-group A rotaviruses and lacking of specific 
reagents. With advance in molecular diagnostic techniques, non-group A rotaviruses have also 
been frequently identified in diarrheic pigs with or without rotavirus A. Notably, rotavirus C was 
most commonly detected in diarrheic neonatal and nursing piglets while detection of rotavirus A 
was more common in association with post-weaning piglet diarrhea according to diagnostic data.  
Furthermore, it was not uncommon to detect more than one group orgenotype of rotavirus in 
feces from diarrheic pigs. Knowing that rotavirus infection is ubiquitous in pig populations, it 
was necessary to better understand the pathogenesis and pathogenicity of different genotypes of 
rotaviruses to explain the observed age disparity in detection frequency of various genotypes and 
devise a better intervention strategy. It was also necessary to develop reagents and laboratory 
tools specific for non-group A rotaviruses in order to support pathobiology studies and aid 
diagnostic investigation and prevention.  
 The current study demonstrated that all group A, B, and C rotaviruses were equally 
pathogenic to immunologically naïve neonatal piglets when given oro-gastrocally under the 
conditions presented during the study. The viruses caused comparable clinical signs including 
diarrhea although fecal shedding of rotavirus B and C started earlier than rotavirus A. 
Interestingly, concurrent infection of more than one serogroup did not exacerbate the severity of 
diarrhea. All serogroups were able to cause atrophic enteritis although distribution of villous 
atrophy within small intestine varied between the serogroups. Nonetheless, there was no 
difference in the distribution of viral antigens or nucleic acid among all fragments of small 
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intestine examined between serogroups. While the current study did not elucidate why rotavirus 
C infection would be more common in neonatal and nursing piglets pathogenicity-wise, a similar 
study should be conducted in older pigs, particularly adult swine to assess each rotavirus 
serogroup’s capability of replication and inducing effective mucosal and lactogenic immunity in 
those pigs.  
In addition to gain of understanding on the pathogenicity of three rotavirus serogroups in 
newborn pigs, the current study produced reagents and tools valuable for studying non-group A 
rotaviruses in vitro and in vivo. First, murine monoclonal antibodies (mabs) specific for VP6 of 
each of porcine rotavirus A, B and C were successfully produced, leading to the development of 
immunohistochemistry (IHC) for porcine rotavirus C in intestinal tissues which was not available. 
The mabs specific for porcine rotavirus B and C that were produced in this study are ‘the first’ of 
its kind to our knowledge and can be useful for development of various diagnostic tests (e.g., 
antigen-capturing ELISA, competitive or blocking ELISA for serology). The availability of mab-
based IHC for porcine rotavirus C may aid accurate diagnosis of rotavirus-associated diarrhea 
leading to a better intervention when concurrent detection of more than one rotavirus serogroup 
in feces from diarrheic pigs is not uncommon. In this sense, an in situ hybridization using 
RNAscope® probe developed in this study for porcine rotavirus B should provide the same utility. 
Second, a group C porcine rotavirus was successfully isolated along with an IPEC-1 cell 
based roller culture system for isolating and maintaining rotavirus C in vitro. There has been 
only one porcine rotavirus C isolate (Cowden strain) which is not available anymore. Then 
porcine rotavirus C isolate IA/2015 (G6P[5]I5) made in this study would be the second of its 
kind and might be the only porcine rotavirus C isolate currently available. The isolate can serve 
as a reference strain and would be useful for future pathobiology studies and vaccine 
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development. The newly established virus isolation method may provide an opportunity to get 
more rotavirus C isolates although the protocol should be evaluated on a large number of 
diagnostic specimens for its effectiveness. 
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